Research activity information

• Intraoperative frozen section analysis of the portal or superior mesenteric vein transection margin in pancreatectomy with venous resection for pancreatic cancer.

  Jun Ishida, Hirochika Toyama, Yoshihide Nanno, Takuya Mizumoto, Dongha Lee, Masayuki Akita, Keisuke Arai, Toshihiko Yoshida, Shinichi So, Takeshi Urade, Kenji Fukushima, Shohei Komatsu, Sadaki Asari, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto

  BACKGROUND: Portomesenteric vein (PMV) resection is performed for pancreatic ductal adenocarcinoma with venous invasion. However, positive transection margins may lead to local recurrence. This study aimed to evaluate whether routine intraoperative frozen section analysis (FSA) reduces positive PMV transection margins. METHODS: This retrospective study reviewed patients who underwent pancreatectomy with PMV resection at Kobe University Hospital from 2010 to 2020. Routine FSA of the PMV transection margin was introduced in 2017. Clinicopathological factors and the incidence of positive PMV transection margins were compared between patients who underwent FSA (PMV frozen [+]) and those who did not (PMV frozen [-]). Cox regression was used to assess the prognostic effect of margin status. RESULTS: A total of 115 patients were included (57 in the PMV frozen [+] group and 58 in the PMV frozen [-] group). The rate of positive PMV transection margins was significantly lower in the PMV frozen (+) group than in the PMV frozen (-) group (1.8% vs 17.2%, respectively; P =.003). Multivariate logistic regression analysis demonstrated that intraoperative FSA of the PMV transection margin was an independent factor associated with a reduced risk of positive PMV transection margins on final pathological diagnosis (odds ratio, 13.7 [95% CI, 1.61-116.7]; P =.017). However, the positive PMV transection margin was not associated with overall survival (hazard ratio, 0.96 [95% CI, 0.31-2.50; P =.937). CONCLUSION: Routine FSA of the PMV transection margin markedly reduces positive PMV transection margins after pancreatectomy. However, the prognostic effect of a positive PMV transection margin remains unclear. Larger prospective studies are needed to determine its prognostic relevance.

  Jun. 2026, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 30(6) (6), 102410 - 102410, English, International magazine

  Scientific journal


• Laparoscopic Anterior-Approach Right Posterior Sectionectomy for Huge Hepatocellular Carcinoma: Technique and Short-Term Outcomes.

  Takeshi Urade, Masahiro Kido, Shohei Komatsu, Kenji Fukushima, Toshihiko Yoshida, Keisuke Arai, Kosuke Iguchi, Masayuki Akita, Takuya Mizumoto, Jun Ishida, Yoshihide Nanno, Hiroaki Yanagimoto, Takumi Fukumoto

  BACKGROUND: Laparoscopic liver resection is technically demanding for hepatocellular carcinoma (HCC) ≥10 cm in the right liver. In open liver resection, the anterior approach is established for large right-lobe tumors because it avoids parenchymal compression during mobilization.1, 2 However, its laparoscopic use remains limited,3 particularly in right posterior sectionectomy (RPS). This study describes the technique and perioperative outcomes of laparoscopic RPS using the anterior approach for huge HCCs. METHODS: Among 799 minimally invasive liver resections performed between 2011 and 2025, four men (median age 72.5 years, range 60-84) with huge tumors (median diameter 11.5 cm, range 10-12) underwent laparoscopic (extended) RPS with an anterior approach. As the tumor bulk caused firm adhesion to the diaphragm and retroperitoneum, the right lobe was left in situ. Parenchymal transection was initiated caudally and progressed cranially along the right inferior vena cava. The specimen was detached only after the transection. Patients were placed in the left hemilateral decubitus position with French lithotomy, and clamp-crushing was used for transection. RESULTS: Two standard and two extended RPSs were completed. The median operative time was 524 minutes (range 418-603), and blood loss was 80 mL (range 10-550); no transfusions were required. The median weight was 753.5 g (range 450-934). No Clavien-Dindo ≥IIIa complications occurred. The median postoperative stay was 11 days (range 9-16). All margins were negative. CONCLUSIONS: Laparoscopic anterior-approach RPS is feasible and safe for huge right posterior HCCs, enabling secure transection without mobilization and yielding favorable short-term outcomes.

  May 2026, Annals of surgical oncology, English, International magazine

  Scientific journal


• The convenience of contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a study protocol for a randomized, prospective, off-label trial.

  Takeshi Urade, Kentaro Oji, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Hayata Sano, Sae Murakami, Takumi Fukumoto

  BACKGROUND: Intraoperative cholangiography (IOC) is widely used to delineate biliary anatomy and confirm ductal integrity during liver resection. However, conventional radiographic IOC requires a C-arm set-up, may interrupt the operative workflow, and exposes patients and operating-room personnel to ionizing radiation. Contrast-enhanced intraoperative ultrasonic cholangiography (CE-IOUSC) combines intrabiliary injection of highly diluted perfluorobutane microbubbles (Sonazoid®) with contrast harmonic ultrasonography, enabling real-time visualization that can be repeated on demand without radiation. We hypothesize that CE-IOUSC provides superior procedural convenience while maintaining biliary visualization and safety. METHODS: This is a single-center, open-label, randomized, parallel-group, phase III comparative trial. Adults (≥ 20 years) scheduled for liver resection, including living donors, are eligible when cholecystectomy and transcystic catheterization via the cystic duct are feasible. After informed consent, participants are randomized 1:1 (stratified by liver condition: normal vs. impaired) to CE-IOUSC or conventional radiographic IOC using a computer-generated sequence. In both arms, cholangiography is performed twice-before and after bile duct division-with additional imaging permitted as clinically required. Conventional IOC uses diluted iothalamate contrast (Urografin®) under C-arm fluoroscopy. CE-IOUSC uses 1,000-fold diluted Sonazoid® administered through the cystic duct and evaluated using intraoperative ultrasonography in contrast mode. Cross-over "rescue" cholangiography with the alternative modality is allowed when the assigned method is unsuccessful or inadequate. The primary endpoint is the cumulative time required to complete intraoperative cholangiography, including any additional imaging and repeated attempts. Secondary endpoints include surgeon-rated usability (5-point Likert questionnaire completed by the primary operator immediately after surgery), detectability of biliary structures (segmental visualization rates assessed by predefined criteria), postoperative biliary complications (bile leak or stricture graded by Clavien-Dindo), cross-over rescue efficacy, and safety outcomes (procedure-related adverse events and perioperative laboratory changes). Outcomes will be analyzed primarily on an intention-to-treat basis. DISCUSSION: This trial will quantify whether CE-IOUSC improves the efficiency and usability of intraoperative biliary imaging without compromising visualization or patient safety. The results will inform evidence-based adoption of ultrasound-based cholangiography as a practical alternative to conventional radiographic IOC in liver resection. TRIAL REGISTRATION: Japan Registry of Clinical Trials (jRCT), jRCTs051230202.

  May 2026, BMC surgery, English, International magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• Delayed Initiation of S-1 Adjuvant Chemotherapy Impairs Survival in Patients With Curatively Resected Pancreatic Cancer.

  Dongha Lee, Hirochika Toyama, Yoshihide Nanno, Hiroyuki Nakamura, Taisuke Okawa, Takuya Mizumoto, Jun Ishida, Masayuki Akita, Keisuke Arai, Toshihiko Yoshida, Shinichi So, Tsuyoshi Urade, Kenji Fukushima, Shohei Komatsu, Sadaki Asari, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto

  BACKGROUND/AIM: The prognostic impact of the timing of adjuvant chemotherapy initiation in patients with resected pancreatic cancer is unclear. Therefore, this study aimed to investigate whether delayed initiation of S-1 adjuvant chemotherapy affects the survival of patients with resectable pancreatic cancer. PATIENTS AND METHODS: Patients who received S-1 adjuvant chemotherapy after undergoing R0/R1 resection were grouped according to whether adjuvant chemotherapy was initiated <60 (n=36) or ≥60 days (n=27) after surgery. Correlations between the time to chemotherapy initiation, clinicopathological factors, and survival were analyzed. RESULTS: The median and mean times to chemotherapy initiation were 58 and 61 days, respectively. The delayed group had worse 2-year overall (57% vs. 80%, p=0.032) and recurrence-free survival (35% vs. 54%, p=0.044) rates than the early group. These results were similar in patients who completed S-1 adjuvant chemotherapy. In multivariate analysis, delayed initiation of chemotherapy, R1 resection, and tumor size (≥40 mm) were independent prognostic factors for poor overall survival. The delayed group had more patients with severe postoperative complications (Clavien-Dindo grade ≥III) (30% vs. 8%, p=0.028) and delayed recovery of serum albumin levels (postoperative days 7, 14, and 30: p=0.040, 0.004, and 0.003, respectively) than the early group. CONCLUSION: Delayed initiation of S-1 adjuvant chemotherapy had an adverse impact on survival and was correlated with severe postoperative complications and delayed recovery of postoperative nutritional status.

  Feb. 2026, Anticancer research, 46(2) (2), 987 - 999, English, International magazine

  Scientific journal


• Exploring the potential utility of modified difficulty scores based on the IWATE criteria for assessing the surgical difficulty of laparoscopic repeat liver resection.

  Hidetoshi Gon, Shohei Komatsu, Tatsuki Kusuhara, Daisuke Takimoto, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Kentaro Tai, Keisuke Arai, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto

  BACKGROUND: Laparoscopic repeat liver resection (LRLR) is more challenging than initial laparoscopic liver resection in some cases because of intra-abdominal adhesions and liver deformation caused by previous operations. However, there are insufficient reports on difficulty scoring systems for LRLR. In this study, we aimed to explore whether the IWATE criteria and its modified scoring system could effectively predict surgical outcomes in patients undergoing LRLR. METHODS: Patients who underwent LRLR at the Kobe University Hospital between 2014 and 2024 were enrolled. We assessed the correlation between difficulty scores based on the IWATE criteria and LRLR surgical outcomes. The correlation between the modified difficulty scores and LRLR surgical outcomes were also evaluated. The modified difficulty scores were calculated by adding 2 points for ipsilateral recurrence and 1 point for a previous history of open liver resection to the original difficulty scores of the IWATE criteria. RESULTS: Eighty-four patients who underwent LRLR were enrolled. The median value of the IWATE criteria and modified difficulty score was 4 and 6, respectively. The median operation time and blood loss were 287 min and 10 mL, respectively. Nineteen (23%) patients experienced postoperative complications, wherein four (5%) had Clavien-Dindo grade ≥ IIIa complications. The IWATE criteria difficulty score correlated with operation time (r = 0.52, 95% confidential interval CI 0.35-0.66, P < 0.001) and blood loss (r = 0.26, 95% CI 0.05-0.45, P = 0.018), while the modified difficulty score correlated with operation time (r = 0.53, 95% CI 0.36-0.67, P < 0.001), blood loss (r = 0.31, 95% CI 0.11-0.49, P = 0.004), and overall postoperative complications (odds ratio 1.34 [interquartile range 1.23, 1.47], P = 0.019). CONCLUSIONS: The IWATE criteria and modified difficulty score may be useful for assessing LRLR surgical difficulty. Additionally, the modified difficulty score may more precisely predict the risk of postoperative complications.

  Dec. 2025, Surgical endoscopy, 39(12) (12), 8228 - 8236, English, International magazine

  Scientific journal


• Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy.

  Nobuaki Ishihara, Shohei Komatsu, Toshifumi Tada, Takanori Matsuura, Eisuke Ueshima, Keitaro Sofue, Masaki Omori, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Kentaro Tai, Toshihiko Yoshida, Keisuke Arai, Hiroaki Yanagimoto, Yuzo Kodama, Takamichi Murakami, Takumi Fukumoto

  INTRODUCTION: Recurrent hepatocellular carcinoma (HCC) after hepatectomy remains a major clinical challenge, necessitating effective prognostic stratification. The oncological resectability criteria recently proposed by the Japan Liver Cancer Association and the Japanese Society of Hepato-Biliary-Pancreatic Surgery have not yet been validated in recurrent settings. This study aimed to evaluate the prognostic utility of these criteria in patients with recurrent HCC after hepatectomy. METHODS: This retrospective study included 505 patients with recurrent HCC following initial hepatectomy. Patients were classified into three groups-resectable (R), borderline resectable 1 (BR1), and borderline resectable 2 (BR2)-based on the oncological resectability criteria. Post-recurrence survival was evaluated using the Kaplan-Meier method, and multivariate analysis was performed to identify clinical factors associated with post-recurrence survival. RESULTS: Among the 505 patients, 248 patients were classified as R, 80 as BR1, and 177 as BR2. The median post-recurrence survival was 73.4 months for the R group, 33.6 months for the BR1 group, and 12.4 months for the BR2 group (p < 0.001). Multivariate analysis identified BR1/BR2 classification (p < 0.001), modified albumin-bilirubin grade 2b or 3 (p < 0.001), and recurrence within 1 year (p = 0.004) as independent predictors of poor post-recurrence survival. CONCLUSIONS: The oncological resectability criteria effectively stratified post-recurrence survival in patients with recurrent HCC. These findings suggest that a multidisciplinary approach may benefit patients with BR1 or BR2 recurrence. Further studies are warranted to explore optimal treatment strategies for recurrent HCC.

  Nov. 2025, Hepatology research : the official journal of the Japan Society of Hepatology, English, International magazine

  Scientific journal


• Assessment of surgical difficulty in multiple laparoscopic liver resection using the aggregate value of scores based on the IWATE criteria.

  Daisuke Takimoto, Hidetoshi Gon, Shohei Komatsu, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Kentaro Tai, Keisuke Arai, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto

  BACKGROUND: No studies exist regarding the methods for evaluating the surgical difficulty of multiple laparoscopic liver resection (MLLR). Hence, this study aimed to evaluate the usefulness of total scores calculated using the IWATE criteria for each resection site to assess the surgical difficulty of MLLR. METHODS: Medical records of patients who underwent MLLR at Kobe University Hospital between 2010 and 2023 were retrospectively reviewed. First, the total difficulty score was calculated for each patient by summing the IWATE criteria scores for all resection sites. Subsequently, we analyzed the correlation between this total difficulty score and surgical outcomes of MLLR. Finally, receiver operating characteristic analysis was employed to determine the optimal cutoff value of the total difficulty score. This cutoff value was used to categorize patients into the high- and low-total difficulty score groups, allowing for a comparison of their surgical outcomes. RESULTS: This study included 63 patients. The total difficulty score correlated with operation time [r = 0.54, 95% confidential interval (CI): 0.34-0.70, P < 0.001] and blood loss (r = 0.27, 95% CI: 0.03-0.90, P = 0.029), and was associated with postoperative complications (odds ratio: 1.33, 95% CI: 1.14-1.60, P < 0.001). Patients with total difficulty scores ≤ 11 and ≥ 12 were included in the low- and high-score groups, respectively. The high-score group exhibited longer operation times (481 min vs. 372 min, P = 0.001), greater blood loss (110 ml vs. 50 ml, P = 0.005), and higher overall complication rates (71% vs. 29%, P = 0.001) than the low-score group. CONCLUSIONS: The total difficulty score based on the IWATE criteria may be a useful tool for assessing surgical difficulty in MLLR.

  Oct. 2025, Surgical endoscopy, English, International magazine

  Scientific journal


• Comparison of the surgical difficulty between segment 7 and 8 partial liver resection untilizing the laparoscopic and open approaches.

  Hidetoshi Gon, Akihiro Fujisawa, Shohei Komatsu, Motofumi Tanaka, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Masahiro Kido, Takumi Fukumoto

  PURPOSE: We aimed to investigate the differences in surgical difficulty between laparoscopic partial liver resections of segments 7 and 8. METHODS: We analyzed 173 patients who underwent partial liver resections of segments 7 or 8 between 2010 and 2022 at two institutions. We investigated differences in the surgical outcomes of each procedure using propensity score matching. We compared these outcomes with those of open partial liver resections for segments 7 and 8 to determine whether the differences were unique to the laparoscopic approach. RESULTS: Thirty and 54 patients underwent laparoscopic partial liver resections of segments 7 and 8. In the matched cohort (22 in each group), the operation time was significantly longer (377 vs. 278 min, P = 0.020) and the proportion of postoperative complications significantly higher in segment 7 (27% vs. 0%, P = 0.008). Forty-one and 48 patients underwent open partial liver resections of segments 7 and 8, respectively. There were no significant differences in the surgical outcomes between the segments in the matched cohort (20 in each group). CONCLUSIONS: Laparoscopic partial liver resections of segment 7 may be more challenging than that of segment 8. This difference in difficulty was not observed in open partial liver resections.

  Oct. 2025, Surgery today, 55(10) (10), 1383 - 1392, English, Domestic magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• Impact of depth of body cavity at the upper-right portion of the abdomen on open and laparoscopic liver resection of segment 7

  Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, Motofumi Tanaka, Masahiro Kido, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto

  Springer Science and Business Media LLC, Jan. 2025, Langenbeck's Archives of Surgery, 410(1) (1)

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• 腫瘍学的切除可能性分類定義に基づいた肝切除・薬物療法成績の検討

  田井 謙太郎, 小松 昇平, 矢野 嘉彦, 石原 伸朗, 木戸 正浩, 権 英寿, 福島 健司, 浦出 剛史, 吉田 俊彦, 荒井 啓輔, 柳本 泰明, 外山 博近, 福本 巧

  (株)医薬情報研究所, Jan. 2025, 新薬と臨牀, 74(1) (1), 24 - 24, Japanese


• A Case of Unresectable Hepatocellular Carcinoma Treated with Spacer Placement Surgery with Bioabsorbable Spacer and Subsequent Proton Beam Therapy.

  Toru Takahashi, Shohei Komatsu, Yusuke Demizu, Keisuke Arai, Nobuaki Ishihara, Akihiro Fujisawa, Hidetoshi Gon, Hirochika Toyama, Sunao Tokumaru, Takumi Fukumoto

  INTRODUCTION: Hepatocellular carcinoma (HCC) often requires repeated therapy and poses challenges in treatment selection, particularly in patients with impaired liver function. Although hepatic resection, radiofrequency ablation, and liver transplantation are standard local curative therapies, the position of radiotherapy, including proton beam therapy (PBT), remains relatively underexplored. Herein, we report an illustrative case of unresectable HCC treated with spacer placement surgery using a bioabsorbable spacer, followed by PBT. CASE PRESENTATION: We report the case of a 77-year-old male patient diagnosed with a 6 cm HCC in segment 8, accompanied by impaired liver function, precluding hepatic resection. PBT was planned; however, because of the proximity of the gastrointestinal tract to the tumor, spacer placement was deemed necessary, and a bioabsorbable polyglycolic acid spacer was placed, followed by PBT. Owing to the sufficient space provided by the spacer, curative doses of PBT could be delivered to the tumor, and the patient survived for 26 months after spacer placement surgery without any sign of recurrence. CONCLUSIONS: Bioabsorbable spacer placement surgery and subsequent PBT are feasible and promising treatment options for unresectable HCC with impaired liver function.

  2025, Surgical case reports, 11(1) (1), English, Domestic magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• Laparoscopic Liver Resection for Hepatocellular Adenomas in Pediatric Glycogen Storage Disease Type Ia: A Case With Consideration for Future Transplantation.

  Kentaro Oji, Takeshi Urade, Ryosuke Bo, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Shinichi So, Toshihiko Yoshida, Kentaro Tai, Keisuke Arai, Takumi Fukumoto

  A 13-year-old girl presented with enlarging hepatocellular adenomas and a history of glycogen storage disease type Ia. Her liver function was well controlled by nutritional therapy. The options of resection and transplantation were considered, and the patient was successfully treated with laparoscopic liver resection. However, pathology revealed fatty liver, indicating that subsequent surgical treatment may be necessary. Herein, we report the patient's clinical progress, including the strategy for determining the surgical approach. In cases where the patient is a low priority for transplantation, laparoscopic liver resection is an important therapeutic choice, even though regrowth of residual lesions has been reported.

  2025, Asian journal of endoscopic surgery, 18(1) (1), e70090, English, Domestic magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma

  NOBUAKI ISHIHARA, SHOHEI KOMATSU, YOSHIHIKO YANO, YOSHIMI FUJISHIMA, JUN ISHIDA, MASAHIRO KIDO, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, TOSHIHIKO YOSHIDA, KENTARO TAI, KEISUKE ARAI, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, TAKANORI MATSUURA, TOSHIFUMI TADA, YUZO KODAMA, TAKUMI FUKUMOTO

  Anticancer Research USA Inc., Dec. 2024, Anticancer Research, 45(1) (1), 251 - 260

  Scientific journal


• 【肝癌診療2024】肝細胞癌集学的治療の進歩

  小松 昇平, 木戸 正浩, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 田井 謙太郎, 荒井 啓輔, 柳本 泰明, 外山 博近, 福本 巧

  (株)へるす出版, Sep. 2024, 消化器外科, 47(9) (9), 1059 - 1070, Japanese


• Comparison of laparoscopic liver resection for the ventral versus the dorsal areas of segment 8.

  Kentaro Oji, Takeshi Urade, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Nobuaki Yamasaki, Kenji Fukushima, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Masayuki Akita, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto

  PURPOSE: The technical difficulties of laparoscopic liver resection (LLR) are greatly associated with the location of liver tumors. Since segment 8 (S8) contains a wide area, the difficulty of LLR for S8 tumors may vary depending on the location within the segment, such as the ventral (S8v) and dorsal (S8d) area, but the difference is unclear. METHODS: We retrospectively investigated 30 patients who underwent primary laparoscopic partial liver resection for liver tumors in S8 at Kobe University Hospital between January 2018 and June 2023. RESULTS: Thirteen and 17 patients underwent LLR for S8v and S8d, respectively. The operation time was significantly longer (S8v 203[135-259] vs. S8d 261[186-415] min, P = 0.002) and the amount of blood loss was significantly higher (10[10-150] vs. 10[10-200] mL, P = 0.034) in the S8d group than in the S8v group. No significant differences were observed in postoperative complications or postoperative length of hospital stay. Additionally, intraoperative findings revealed that the rate at which the case performed partial liver mobilization in the S8d group was higher (2[15.4%] vs. 8[47.1%], P = 0.060) and the median parenchymal transection time of the S8d group was longer (102[27-148] vs. 129[37-175] min, P = 0.097) than those in the S8v group, but there were no significant differences. CONCLUSION: The safety of LLR for the S8d was comparable to that of LLR for S8v, although LLR for S8d resulted in longer operative time and more blood loss. THE TRIAL REGISTRATION NUMBER: B230165 (approved at December 26, 2023).

  Aug. 2024, Langenbeck's archives of surgery, 409(1) (1), 243 - 243, English, International magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• [A Case of Radical Hepatectomy in a Patient with Recurrent Liver Metastasis of Gallbladder Cancer after Successful Chemotherapy with GC+Durvalumab].

  Taiichiro Miyake, Takeshi Urade, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Shinichi So, Keisuke Arai, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Masahiro Kido, Takumi Fukumoto

  A 49-year-old man underwent an open cholecystectomy for advanced gallbladder cancer in 2021. Three months after surgery, the patient underwent an additional resection, which showed no malignant findings, but 12 months after surgery, contrast-enhanced CT and MRI showed a new mass lesion in segment 8 of the liver, and the patient was diagnosed with postoperative hepatic metastatic recurrence of gallbladder cancer. After referral to our institution, he received 1 course of gemcitabine+cisplatin(GC)therapy and 8 courses of gemcitabine+cisplatin+durvalumab(GCD)therapy. Contrast- enhanced CT and MRI showed that the metastases had shrunk, and PET scan showed no FDG accumulation. Two months after completion of chemotherapy, there was no evidence of metastatic enlargement and new metastasis including distant metastasis, and the patient was referred to our department. Since curative resection was expected, a laparoscopic partial hepatectomy of segment 8 of the liver was performed. Pathological diagnosis revealed no residual tumor. If the metastases could be well controlled by systemic chemotherapy, hepatectomy for hepatic metastases of biliary tract cancer could be a treatment option.

  Aug. 2024, Gan to kagaku ryoho. Cancer & chemotherapy, 51(8) (8), 843 - 845, Japanese, Domestic magazine

  Scientific journal


• GC+デュルバルマブ療法が奏効し根治的肝切除術を施行し得た胆嚢癌術後肝転移再発の1例

  三宅 泰一郎, 浦出 剛史, 小松 昇平, 権 英寿, 福島 健司, 宗 慎一, 荒井 啓輔, 浅利 貞毅, 柳本 泰明, 外山 博近, 木戸 正浩, 福本 巧

  (株)癌と化学療法社, Aug. 2024, 癌と化学療法, 51(8) (8), 843 - 845, Japanese


• Impact of bile leak on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection.

  Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, Motofumi Tanaka, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Masahiro Kido, Takumi Fukumoto

  PURPOSE: The impact of postoperative bile leak on the prognosis of patients with hepatocellular carcinoma who underwent liver resection is controversial. This study aimed to investigate the prognostic impact of bile leak for patients with hepatocellular carcinoma who underwent liver resection. METHODS: Patients with hepatocellular carcinoma who underwent liver resection between 2009 and 2019 at Kobe University Hospital and Hyogo Cancer Center were included. After propensity score matching between the bile leak and no bile leak groups, differences in 5-year recurrence-free and overall survival rates were evaluated using the Kaplan-Meier method. RESULTS: A total of 781 patients, including 43 with postoperative bile leak, were analyzed. In the matched cohort, 40 patients were included in each group. The 5-year recurrence-free survival rates after liver resection were 35% and 32% for the bile leak and no bile leak groups, respectively (P = 0.857). The 5-year overall survival rates were 44% and 54% for the bile leak and no bile leak groups, respectively (P = 0.216). CONCLUSION: Overall, bile leak may not have a profound negative impact on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection.

  Jul. 2024, Langenbeck's archives of surgery, 409(1) (1), 233 - 233, English, International magazine

  Scientific journal


• Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report.

  Nobuaki Ishihara, Shohei Komatsu, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Keisuke Arai, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto

  Tremelimumab plus durvalumab (Dur/Tre) is the first-line treatment for advanced hepatocellular carcinoma (HCC) worldwide. The present report describes the case of a 68-year-old man diagnosed with advanced HCC and a bile duct tumor thrombus (BDTT) who achieved a complete response to Dur/Tre therapy. The BDTT progressed to the bifurcation of the left and right hepatic ducts. Over time, both the tumors and BDTT progressively decreased in size, and a complete response was confirmed using the Response Evaluation Criteria in Solid Tumors (version 1.1.) 6 months after treatment administration. Subsequently, immune-related adverse events, including type 1 diabetes mellitus and diabetic ketoacidosis, emerged, leading to treatment discontinuation. The patient was undergoing outpatient follow-up in a drug-free state with no signs of recurrence 290 days after the initial administration of Dur/Tre. Although long-term and meticulous observations are required, the present findings could influence the choice of systemic chemotherapy for advanced HCC.

  Jul. 2024, Oncology letters, 28(1) (1), 332 - 332, English, International magazine

  Link to Kobe Univ. Repository (Kernel)


• Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.

  Akira Koizumi, Shohei Komatsu, Satoshi Omiya, Yoshihiko Yano, Yoshimi Fujishima, Jun Ishida, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Ryosuke Fujinaka, Yuhi Shimura, Hiroaki Yanagimoto, Hirochika Toyama, Yoshihide Ueda, Yuzo Kodama, Takumi Fukumoto

  BACKGROUND/AIM: The treatment algorithm for systemic therapies for advanced hepatocellular carcinoma (HCC) has changed dramatically; however, the therapeutic landscape for sequential second-line or later-line treatments, including ramucirumab, remains controversial. This study aimed to investigate the role of ramucirumab for treating HCC. PATIENTS AND METHODS: We retrospectively analyzed data from 17 patients with advanced HCC who received ramucirumab, and 8 of them who received lenvatinib re-administration after ramucirumab treatment failure. RESULTS: The median overall survival of 17 patients treated with ramucirumab was 11.5 months. The median ratios of the 1-month post-treatment α-fetoprotein (AFP) levels and albumin-bilirubin (ALBI) scores to the pre-treatment AFP levels and ALBI scores following ramucirumab treatment were 0.880 and 0.965, respectively. The median ratios of the 1-month post-treatment AFP and ALBI levels to the pre-treatment levels were 1.587 and 0.970 for mALBI grade 1/2a, and 1.313 and 0.936 for mALBI grade 2b/3, respectively. Six of the eight patients who received lenvatinib rechallenge treatment exhibited a decrease in AFP levels one month post-lenvatinib treatment. Deterioration of liver function 3 months post-lenvatinib treatment was noted in five of the eight patients who received lenvatinib rechallenge treatment after ramucirumab. CONCLUSION: Ramucirumab may be equally useful in patients with unresectable HCC who have poor liver function or whose liver function is aggravated by other therapies. Rechallenge treatment with lenvatinib after ramucirumab may be a valid treatment option for HCC.

  May 2024, Anticancer research, 44(5) (5), 2055 - 2061, English, International magazine

  Scientific journal


• The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection

  HIDETOSHI GON, SHOHEI KOMATSU, SATOSHI OMIYA, MASAHIRO KIDO, KENJI FUKUSHIMA, TAKESHI URADE, TOSHIHIKO YOSHIDA, KEISUKE ARAI, JUN ISHIDA, YOSHIHIDE NANNO, DAISUKE TSUGAWA, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, TAKUMI FUKUMOTO

  Anticancer Research USA Inc., Apr. 2024, Anticancer Research, 44(5) (5), 2031 - 2038

  Scientific journal


• Utility of plasma D-dimer for diagnosis of venous thromboembolism after hepatectomy.

  Taiichiro Miyake, Hiroaki Yanagimoto, Daisuke Tsugawa, Masayuki Akita, Riki Asakura, Keisuke Arai, Toshihiko Yoshida, Shinichi So, Jun Ishida, Takeshi Urade, Yoshihide Nanno, Kenji Fukushima, Hidetoshi Gon, Shohei Komatsu, Sadaki Asari, Hirochika Toyama, Masahiro Kido, Tetsuo Ajiki, Takumi Fukumoto

  BACKGROUND: Venous thromboembolism (VTE) is a potentially fatal complication of hepatectomy. The use of postoperative prophylactic anticoagulation in patients who have undergone hepatectomy is controversial because of the risk of postoperative bleeding. Therefore, we hypothesized that monitoring plasma D-dimer could be useful in the early diagnosis of VTE after hepatectomy. AIM: To evaluate the utility of monitoring plasma D-dimer levels in the early diagnosis of VTE after hepatectomy. METHODS: The medical records of patients who underwent hepatectomy at our institution between January 2017 and December 2020 were retrospectively analyzed. Patients were divided into two groups according to whether or not they developed VTE after hepatectomy, as diagnosed by contrast-enhanced computed tomography and/or ultrasonography of the lower extremities. Clinicopathological factors, including demographic data and perioperative D-dimer values, were compared between the two groups. Receiver operating characteristic curve analysis was performed to determine the D-dimer cutoff value. Univariate and multivariate analyses were performed using logistic regression analysis to identify significant predictors. RESULTS: In total, 234 patients who underwent hepatectomy were, of whom (5.6%) were diagnosed with VTE following hepatectomy. A comparison between the two groups showed significant differences in operative time (529 vs 403 min, P = 0.0274) and blood loss (530 vs 138 mL, P = 0.0067). The D-dimer levels on postoperative days (POD) 1, 3, 5, 7 were significantly higher in the VTE group than in the non-VTE group. In the multivariate analysis, intraoperative blood loss of > 275 mL [odds ratio (OR) = 5.32, 95% confidence interval (CI): 1.05-27.0, P = 0.044] and plasma D-dimer levels on POD 5 ≥ 21 μg/mL (OR = 10.1, 95%CI: 2.04-50.1, P = 0.0046) were independent risk factors for VTE after hepatectomy. CONCLUSION: Monitoring of plasma D-dimer levels after hepatectomy is useful for early diagnosis of VTE and may avoid routine prophylactic anticoagulation in the postoperative period.

  Jan. 2024, World journal of clinical cases, 12(2) (2), 276 - 284, English, International magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• 膵癌術後再発に対する治療戦略の現状と展望

  南野 佳英, 外山 博近, 浅利 貞毅, 後藤 直大, 石田 潤, 福岡 裕貴, 阿見 勝也, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 権 英寿, 津川 大介, 小松 昇平, 蔵満 薫, 柳本 泰明, 木戸 正浩, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 549 - 549, Japanese


• 当院における術後胆管狭窄症例に対する対応と検討

  津川 大介, 柳本 泰明, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 365 - 365, Japanese


• 肝外胆管癌切除後S-1補助化学療法例におけるGLIM基準の有用性に関する検討

  柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 366 - 366, Japanese


• 肝切除術後の門脈血栓症に対するエドキサバンの治療成績

  藤中 亮輔, 浦出 剛史, 木戸 正浩, 蔵満 薫, 小松 昇平, 権 英寿, 福島 健司, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 529 - 529, Japanese


• 肝門部胆管癌術後の術後胆汁漏の検討

  三宅 泰一郎, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 536 - 536, Japanese


• 肝外胆管癌における術前骨格筋量減少の術後早期再発への影響

  岡副 佑城, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本消化器外科学会, Nov. 2023, 日本消化器外科学会雑誌, 56(Suppl.2) (Suppl.2), 538 - 538, Japanese


• 胆道癌における再発時期と再発形式の検討

  吉田 道彦, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一財)日本消化器病学会, Oct. 2023, 日本消化器病学会雑誌, 120(臨増大会) (臨増大会), A825 - A825, Japanese


• 膵疾患に対する高齢者医療の現状と課題 高齢者に対する膵全摘,残膵全摘の短期・長期成績について

  石田 潤, 外山 博近, 浅利 貞毅, 後藤 直大, 南野 佳英, 阿見 勝也, 福岡 裕貴, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 権 英寿, 津川 大介, 小松 昇平, 蔵満 薫, 柳本 泰明, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本膵臓学会, Jul. 2023, 膵臓, 38(3) (3), A240 - A240, Japanese


• Advantages of the Laparoscopic Approach for the Initial Operation in Patients who Underwent Repeat Hepatectomy.

  Hidetoshi Gon, Shohei Komatsu, Masahiro Kido, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto

  BACKGROUND: Less intra-abdominal adhesions are expected following laparoscopic surgery. Although an initial laparoscopic approach for primary liver tumors may have advantages in patients who require repeat hepatectomies for recurrent liver tumors, this has not been sufficiently investigated. METHODS: Patients who underwent repeat hepatectomies for recurrent liver tumors at our hospital between 2010 and 2022 were retrospectively analyzed. Of 127 patients, 76 underwent laparoscopic repeat hepatectomy (LRH), of whom 34 patients initially underwent laparoscopic hepatectomy (L-LRH) and 42, open hepatectomy (O-LRH). Fifty-one patients underwent open hepatectomy as both the initial and second operation (O-ORH). We analyzed surgical outcomes between L-LRH and O-LRH groups and between L-LRH and O-ORH groups using propensity-matching analysis for each pattern. RESULTS: Twenty-one patients each were included in L-LRH and O-LRH propensity-matched cohorts. The L-LRH group had a lower rate of postoperative complications than the O-LRH group (0 vs 19%, P = 0.036). When we compared surgical outcomes between L-LRH and O-ORH groups in another matched cohort with 18 patients in each group, in addition to the lower rate of postoperative complications, the L-LRH group had additional favorable surgical outcomes including shorter operation time and lower blood loss volume than the O-ORH group (291 vs 368 min, P = 0.037 and 10 vs 485 mL, P < 0.0001). CONCLUSIONS: An initial laparoscopic approach would be favorable for patients undergoing repeat hepatectomies, as it leads to lower risk of postoperative complications. Compared with O-ORH, the advantage of the laparoscopic approach may be enhanced when it is repeatedly adopted.

  Jun. 2023, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 27(8) (8), 1621 - 1631, English, International magazine

  Scientific journal


• Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective Study.

  Yuhi Shimura, Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Daisuke Tsugawa, Tadahiro Goto, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Tetsuo Ajiki, Takumi Fukumoto

  BACKGROUND: Post-transplantation weight control is important for long-term outcomes; however, few reports have examined postoperative weight change. This study aimed to identify perioperative factors contributing to post-transplantation weight change. METHODS: Twenty-nine patients who underwent liver transplantation between 2015 and 2019 with an overall survival of >3 years were analyzed. RESULTS: The median age, model for end-stage liver disease score, and preoperative body mass index (BMI) of the recipients were 57, 25, and 23.7, respectively. Although all but one recipient lost weight, the percentage of recipients who gained weight increased to 55% (1 month), 72% (6 months), and 83% (12 months). Among perioperative factors, recipient age ≤50 years and BMI ≤25 were identified as risk factors for weight gain within 12 months (P < .05), and patients with age ≤50 years or BMI ≤25 recipients gained weight more rapidly (P < .05). The recovery time of serum albumin level ≥4.0 mg/dL was not statistically different between the 2 groups. The weight change during the first 3 years after discharge was represented by an approximately straight line, with 18 and 11 recipients showing a positive and negative slope, respectively. Body mass index ≤23 was identified as a risk factor for a positive slope of weight gain (P <.05). CONCLUSIONS: Although postoperative weight gain implies recovery after transplantation, recipients with a lower preoperative BMI should strictly manage body weight as they may be at higher risk of rapid weight increase.

  May 2023, Transplantation proceedings, 55(4) (4), 924 - 929, English, International magazine

  Scientific journal

  Link to Kobe Univ. Repository (Kernel)


• ロボット支援下膵体尾部切除導入期に直面する技術的問題点

  外山 博近, 後藤 直大, 南野 佳英, 石田 潤, 福岡 裕貴, 阿見 勝也, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 権 英寿, 津川 大介, 小松 昇平, 蔵満 薫, 浅利 貞毅, 柳本 泰明, 木戸 正浩, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• Taking antithrombic therapy during emergency laparoscopic cholecystectomy for acute cholecystitis does not affect the postoperative outcomes: a propensity score matched study.

  Kentaro Oji, Yasunori Otowa, Yuta Yamazaki, Keisuke Arai, Yasuhiko Mii, Keitaro Kakinoki, Tetsu Nakamura, Daisuke Kuroda

  BACKGROUND: Continuing antithrombic therapy (ATT) during surgery increases the risk of bleeding. However, it is difficult to discontinue the ATT in emergency surgery. Therefore, safety of emergency laparoscopic cholecystectomy (LC) for acute cholecystitis (AC) is still unclear. We aimed to clarify the affect of ATT during emergency LC for AC. METHODS: Patients with AC were classified into ATT group (n = 30) and non-ATT group (n = 120). Postoperative outcomes were compared after propensity score matching (n = 22). RESULTS: Higher level of c-reactive protein level and shorter activated partial thromboplastin time (APTT) was observed in ATT group than in non-ATT group after matching. No significant difference was found between other patient characteristics and perioperative results. Blood loss over 100 mL was observed in 8 patients. Multivariate analyze showed that APTT was an independent risk factor for bleeding over 100 mL (P = 0.039), while ACT and APT was not. CONCLUSIONS: Taking ATT does not affect the blood loss or complications during emergency LC for AC. Controlling intraoperative bleeding is essential for a safe postoperative outcome.

  Feb. 2022, BMC surgery, 22(1) (1), 42 - 42, English, International magazine

  Scientific journal


• Distance of Peritoneum to Inferior Mesenteric Artery Predicts the Operation Time During Laparoscopic Colectomy for Sigmoid or Rectosigmoid Colon Cancer.

  Takafumi Saeki, Yasunori Otowa, Yuta Yamazaki, Keisuke Arai, Takashi Shimizu, Yasuhiko Mii, Keitaro Kakinoki, Shigeteru Oka, Tetsu Nakamura, Daisuke Kuroda

  BACKGROUND/AIM: Obesity is a major technical limiting factor for laparoscopic surgery because abundant visceral fat is known to extend the operation time. However, special hardware is needed to assess it. We hypothesized that the depth from the peritoneum to the bifurcation of the inferior mesenteric artery (IMA) defined as 'peritoneum to IMA distance (PID)' might be a simple predictive factor for extended operation time during laparoscopic colectomy. PATIENTS AND METHODS: One hundred twenty-four patients who were diagnosed with sigmoid or rectosigmoid colon cancer and underwent laparoscopic colectomy were included. The patients were divided into two groups based on the operation time (210 min). The vertical distance from the peritoneum to the bifurcation of the inferior mesenteric artery was defined as PID. The factors eliciting an operation time longer than 210 min were investigated. RESULTS: There was significant difference in sex, BMI, cT, cN, and PID between the Early group (<210 min) and Late group (≥210 min). Less blood loss was observed in the Early group than in the Late group. Multivariate analysis showed that PID was the only independent factor that affected operation time (p<0.001). CONCLUSION: PID predicts the operation time during laparoscopic colectomy for sigmoid or rectosigmoid colon cancer.

  2022, Cancer diagnosis & prognosis, 2(2) (2), 240 - 246, English, International magazine

  Scientific journal


• Purse-string suture after ligating by endoloop for closing of the appendiceal stump is an alternative for endostapler in selected cases: A propensity score-matched study.

  Shuji Okamoto, Yasunori Otowa, Ryosuke Fujinaka, Keisuke Arai, Koichi Murata, Yasuhiko Mii, Keitaro Kakinoki, Shigeteru Oka, Shingo Kanaji, Yoshihiro Kakeji, Daisuke Kuroda

  INTRODUCTION: The closure of the appendiceal stump is a crucial part of a laparoscopic appendectomy, and an endoloop or endostapler is generally used. The endoloop can be more cost effective than the endostapler. However, reports have shown that the endoloop has a higher postoperative abdominal abscess rate than the endostapler in complicated appendicitis. At our institution, we perform a purse-string suture after ligating by endoloop to reduce postoperative abdominal abscess risk. This study aimed to clarify whether this method could reduce the incidence of postoperative abdominal abscess compared with the endostapler. METHODS: Patients with acute appendicitis were classified into the purse-string suture group (n = 149) and the endostapler group (n = 82). Postoperative outcomes were compared after propensity score matching (n = 47). RESULTS: No significant difference was found between the two groups in terms of the patient characteristics and postoperative complications, including abdominal abscess. However, the purse-string suture group had more drain placement and a shorter hospital stay than the endostapler group (P = .04 and P = .02, respectively). In patients with complicated appendicitis, there was less drain placement and a shorter hospital stay in the purse-string suture group than in the endostapler group (P < .01 and P < .01, respectively). This might have reflected the difficulty of the operation. All postoperative abdominal abscesses occurred in complicated appendicitis cases. CONCLUSIONS: Endoloop with additional purse-string suture had a lower incidence of abscess than previous reports of using endoloop alone. Moreover, the postoperative abdominal abscess rate is similar between the two closure methods.

  Oct. 2021, Asian journal of endoscopic surgery, 14(4) (4), 775 - 781, English, Domestic magazine

  Scientific journal


• Aortic Rupture due to Co-localization of Aortic Intimal Myofibroblastic Sarcoma and Urothelial Carcinoma: A Unique Case Report.

  Yutaka Ohashi, Yuki Yamamoto, Akitoshi Yamada, Kazuhiro Yamamoto, Keisuke Arai, Fumiko Namba, Naokazu Miyamoto, Masaru Tomita, Takeshi Fukumoto, Tsutomu Minamikawa, Masahiro Oka

  We herein report a unique case of aortic rupture due to co-localization of aortic intimal myofibroblastic sarcoma (IMFS) and urothelial carcinoma (UC). A 76-year-old man who was being followed up after surgery for UC 5 years earlier developed aortic rupture and underwent emergency surgery. Intraoperatively, a tumorous mass on the luminal side of the aortic arch was found near the rupture. A histopathological analysis of the mass revealed aortic IMFS. Furthermore, co-localization of IMFS and UC cells was found near the rupture. The fragility of the aortic wall due to co-localization of IMFS and UC was believed to contribute to the aortic rupture.

  Jan. 2021, Internal medicine (Tokyo, Japan), 60(2) (2), 269 - 274, English, Domestic magazine

  Scientific journal


• Pathologic complete response after preoperative chemotherapy with a regimen containing trastuzumab in esophagogastric junction adenocarcinoma: A case report

  Keisuke Arai, Shingo Kanaji, Daiki Okamoto, Ritsuko Maehara, Masashi Yamamoto, Tetsu Nakamura, Satoshi Suzuki, Naoe Jimbo, Yukiko Morinaga, Tomoo Itoh, Yoshihiro Kakeji

  International College of Surgeons, 2021, International Surgery, 105(1) (1), 152 - 156, English

  Scientific journal


• Surgical resection for liver metastases developing 10 and 21 years after primary surgery for mucinous colon adenocarcinoma: A case report

  Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Nobuya Kusunoki, Masahiro Kido, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku

  International College of Surgeons, Nov. 2019, International Surgery, 103(11-12) (11-12), 517 - 522, English

  Scientific journal


• [Adjuvant Chemotherapy for High-Risk Stage Ⅱ Colon Cancer].

  Ryosuke Fujinaka, Yasunori Otowa, Hiroki Yokoo, Keisuke Arai, Koichi Murata, Yasuhiko Mii, Keitaro Kakinoki, Shigeteru Oka, Daisuke Kuroda

  BACKGROUND: This study was designed to clarify effects of postoperative adjuvant chemotherapy for high-risk Stage Ⅱ colorectal cancer. METHOD: The subjects were 99 patients with high-risk Stage Ⅱcolorectal cancer who underwent surgery at our department from October 2013 to March 2018. Patients were classified into adjuvant chemotherapy group and nonadjuvant chemotherapy group. Overall survival(OS)and recurrence-free survival(RFS)were analyzed between the 2 groups. RESULTS: Thirty six patients(36.4%)underwent adjuvant chemotherapy. Adjuvant chemotherapy group were younger(p<0.010), had a better ASA-PS(p<0.010), good preoperative Hb(p<0.010), and preoperative Alb(p<0.010)compared to non-adjuvant chemotherapy group. There was no difference between the 2 groups in the high-risk factors for recurrence. Most patient had an oral medication as for adjuvant chemotherapy. There was no difference in OS and RFS between the 2 groups. CONCLUSION: Postoperative adjuvant chemotherapy for high-risk Stage Ⅱ colorectal cancer did not significantly improve the OS and RFS. Further study is necessary to asses the suitable regimen and patients eligible for chemotherapy.

  Aug. 2019, Gan to kagaku ryoho. Cancer & chemotherapy, 46(8) (8), 1327 - 1329, Japanese, Domestic magazine

  Scientific journal


• [Preoperative Chemotherapy with DCF for Advanced Esophageal Cancer].

  Koichi Murata, Daisuke Kuroda, Shuji Okamoto, Ryosuke Fujinaka, Keisuke Arai, Yasunori Otowa, Yasuhiko Mii, Keitaro Kakinoki, Mariko Mani, Shigeteru Oka

  We conducted a retrospective study to evaluate the efficacy and the problem of the neoadjuvant chemotherapy using DCF for cStage Ⅲ/Ⅳ(squamous cell)esophageal cancer. Eleven patients from January 2017 to December 2018 were enrolled into this study. The median age was 67 years old, male/female ratio was 9:2, performance status was 0 in all patients, and UICC cStage Ⅲ/Ⅳa was 7:4. Cycles of chemotherapy was 2 in 1 patients, 3 in 5 patients and additional 2 courses in 1 patient. Four patients switched to FP therapy after a course of DCF. The efficacy of chemotherapy was evaluated by the clinical response rate, average tumor reduction rate, and histological therapeutic effect rate over Grade 2 which was 63.6%, 48.3%, and 40%, respectively. Neutropenia over Grade 3 was observed in all patients and Grade 4 was observed in 6 patients. In conclusion, preoperative chemotherapy with DCF therapy is useful for the treatment of cStage Ⅲ/Ⅳ(squamous cell) esophageal cancer as long as bone marrow suppression is managed.

  Aug. 2019, Gan to kagaku ryoho. Cancer & chemotherapy, 46(8) (8), 1337 - 1339, Japanese, Domestic magazine

  Scientific journal


• Feasibility and Effectiveness of Gastrectomy for Elderly Gastric Cancer Patients.

  Yasunori Otowa, Shuji Okamoto, Ryosuke Fujinaka, Keisuke Arai, Koichi Murata, Yasuhiko Mii, Keitaro Kakinoki, Shigeteru Oka, Daisuke Kuroda

  BACKGROUND/AIM: The benefits of gastrectomy for elderly gastric cancer (GC) patients remain unknown. The aim of this study was to evaluate the validity of gastrectomy. PATIENTS AND METHODS: Patients who had R0 or R1 resection and diagnosed as pathological Stage I-III GC were enrolled in this study. Patients were classified according to age: Elderly group (≥80 years old), non-Elderly group (70-79 years old), Standard group (≤69 years old). RESULTS: As the age raised, the number of comorbidities increased and patients had a worse physical status. Operative procedure and postoperative complications of the Elderly group were similar to that of the non-Elderly group. The overall survival was similar in pathological Stages I and III between the Elderly and non-Elderly groups, while the Stage II Elderly group had shorter overall survival. Also, the Elderly group did not undergo adjuvant chemotherapy compared to other groups. CONCLUSION: Gastrectomy can be performed safely in elderly patients following gastrectomy, survival of elderly patients was similar to non-elderly patients. Therefore, gastrectomy is an acceptable treatment for elderly patients in good condition.

  2019, In vivo (Athens, Greece), 33(4) (4), 1307 - 1311, English, International magazine

  Scientific journal


• Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.

  Keisuke Arai, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku

  PURPOSE: We assessed the predictive value of the preoperative neutrophil-to-lymphocyte ratio (NLR) in patients who underwent a two-stage treatment combining reductive surgery and percutaneous isolated hepatic perfusion for multiple hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). METHODS: Forty-two patients underwent the two-stage treatment between January 2000 and December 2014 at Kobe University Hospital (Hyogo, Japan). The NLR was calculated from lymphocyte and neutrophil counts in the preoperative routine blood test. Clinical data and overall survival were compared statistically and multivariate analysis was done to identify prognostic factors. RESULTS: The median survival of patients with a preoperative NLR > 2.3 was 14.9 months (n = 13), whereas that of patients with a preoperative NLR ≤ 2.3 was 26.1 months (n = 29; P = 0.022). A preoperative NLR > 2.3 was an independent prognostic factor in patients with multiple HCC with PVTT [hazard ratio (HR) 2.329; 95 % confidence interval (CI) 1.058-5.667; P = 0.036]. CONCLUSION: Based on the results of this study, an elevated preoperative NLR is an independent predictive risk factor for patients undergoing two-stage treatment for multiple HCC with PVTT.

  Mar. 2017, Surgery today, 47(3) (3), 385 - 392, English, Domestic magazine

  Scientific journal


• Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report.

  Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku

  BACKGROUND: Although the effectiveness of perioperative adjuvant therapy in the treatment of hepatocellular carcinoma (HCC) has been investigated, the efficacy of preoperative therapy is unclear. Herein, we report a case of pathological complete response after percutaneous isolated hepatic perfusion (PIHP) for HCC involving portal vein tumor thrombosis (PVTT). CASE PRESENTATION: A 77-year-old woman was referred to our institute with a liver mass detected on a routine health screening. Computed tomography revealed a 28 × 25 mm HCC in the left lobe of the liver and a tumor thrombus in the left and right portal branches (T4N0M0, stage IVA). The patient received a single dose of preoperative PIHP with doxorubicin plus mitomycin C, without severe toxicity. After the chemotherapy, she underwent extended left hepatic lobectomy and thrombectomy of the PVTT. No cancer cells were detected during histopathological analysis, indicating pathological complete response. She remained relapse-free 12 months after the surgery. CONCLUSIONS: We experienced a case of pathological complete response after preoperative PIHP with doxorubicin plus mitomycin C for HCC involving PVTT.

  Dec. 2016, Surgical case reports, 2(1) (1), 50 - 50, English, International magazine

  Scientific journal


• A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation.

  Keisuke Arai, Kaori Kuramitsu, Takumi Fukumoto, Masahiro Kido, Atsushi Takebe, Motofumi Tanaka, Hisoka Kinoshita, Tetsuo Ajiki, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Yonson Ku

  There are few descriptions of severe thrombocytopenia during the early postoperative period after liver transplantation, and these have not been fully documented in the literature. Here, we report a case of drug-induced thrombocytopenia requiring transfusion of blood products after living donor liver transplantation. We determined that this was not caused by the interferon-free anti-viral therapy but by tacrolimus A 61-year-old woman with hepatitis C-related cirrhosis and hepatorenal syndrome underwent living donor liver transplantation using a left lobe graft from her son. After transplantation, immunosuppression consisted of tacrolimus and steroid. Seven weeks after transplantation, interferon-free therapy with daclatasvir and asunaprevir was started. Thirteen days thereafter, hepatitis C virus tested negative. However, the platelet count had begun to gradually decrease just before starting anti-viral therapy. Daclatasvir and asunaprevir were stopped because this was suspected to be a side-effect of these drugs, but the patient nonetheless went on to develop severe thrombocytopenia (platelet count 17,000/μL), which needed transfusions. Now suspecting tacrolimus as the inducer of this side effect, we changed to cyclosporin, after which the platelet count gradually recovered. Viral markers were still not detectable up to 2 months after discontinuation of the antiviral drugs. We conclude that when severe thrombocytopenia occurs, possible drug-induced thrombocytopenia as well as other disorders must be investigated.

  Jun. 2016, The Kobe journal of medical sciences, 62(1) (1), E9-E12, English, Domestic magazine

  Scientific journal


• Low-Dose Antiviral Treatment for Hepatitis C Virus Following Living Donor Liver Transplantation without Splenectomy

  Toshihiko Yoshida, Atsushi Takebe, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shinichi So, Keisuke Arai, Yonson Ku

  May 2016, TRANSPLANTATION, 100, S211 - S211, English

• 肥満症例における右横隔膜下領域の肝切除に対する腹腔鏡アプローチの有用性

  権英寿, 木戸正浩, 田中基文, 小松昇平, 福島健司, 浦出剛史, 宗慎一, 吉田俊彦, 田井謙太郎, 荒井啓輔, 秋田真之, 水本拓也, 石田潤, 南野佳英, 津川大介, 浅利貞毅, 柳本泰明, 外山博近, 福本巧

  2025, 日本外科学会定期学術集会(Web), 125th


• Vp4巨大肝細胞癌に対して経鼻栄養下にDurvalumab+Tremelimumab併用療法を施行しconversion肝切除を達成した1例

  佐野隼大, 福島健司, 小松昇平, 木戸正浩, 権英寿, 浦出剛史, 宗慎一, 吉田俊彦, 田井謙太郎, 荒井啓輔, 井口浩輔, 水本拓也, 石田潤, 南野佳英, 津川大介, 浅利貞毅, 柳本泰明, 外山博近, 児玉貴之, 福本巧

  2025, 日本肝がん分子標的治療研究会プログラム・抄録集, 32nd


• 肝細胞癌症例における肝切除術後胆汁漏の予後への影響についての検討

  権英寿, 木戸正浩, 田中基文, 小松昇平, 福島健司, 浦出剛史, 宗慎一, 吉田俊彦, 荒井啓輔, 曽山弘敏, 石田潤, 南野佳英, 津川大介, 浅利貞毅, 柳本泰明, 外山博近, 福本巧

  2024, 日本消化器外科学会雑誌(Web), 57(Supplement2) (Supplement2)


• Under 40外科医が専門医取得の次に目指すもの

  荒井 啓輔, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, HFT - 2, Japanese


• 正確な局所解剖に基づいた肝細胞癌に対する合理的肝切除術とは 初回再発形式からみる表在性肝細胞癌に対する非系統的切除術の妥当性に関する検討

  西尾 公佑, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, SY - 2, Japanese


• 胆道癌に対するS-1術後補助化学療法と早期再発の関連

  吉田 道彦, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 南野 佳英, 浦出 剛, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, SF - 6[Y], Japanese


• 肝移植後長期成績向上のために,何が必要か

  蔵満 薫, 小松 昇平, 木戸 正浩, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 南野 佳英, 津川 大介, 後藤 直大, 柳本 泰明, 浅利 貞毅, 味木 徹夫, 外山 博近, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 7, Japanese


• 術前化学療法後に切除を施行したBR-A膵癌,UR-LA膵癌における早期再発risk因子の検討

  阿見 勝也, 外山 博近, 浅利 貞毅, 後藤 直大, 南野 佳英, 石田 潤, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 権 英寿, 津川 大介, 小松 昇平, 蔵満 薫, 柳本 泰明, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 2, Japanese


• ロボット支援下膵体尾部切除導入期に直面する技術的問題点

  外山 博近, 後藤 直大, 南野 佳英, 石田 潤, 福岡 裕貴, 阿見 勝也, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 権 英寿, 津川 大介, 小松 昇平, 蔵満 薫, 浅利 貞毅, 柳本 泰明, 木戸 正浩, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• 大腸癌肝転移における予後予測因子としての全腫瘍体積の有用性と,適切な化学療法導入時期に関する観察研究

  志村 雄飛, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 南野 佳英, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 1, Japanese


• 治療成績から見た大腸癌肝転移における切除可能性分類と治療戦略

  吉田 俊彦, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• 当科における吸収性スペーサー留置術22例の臨床経過

  山崎 伸明, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• 肝細胞癌切除症例におけるGLIM基準と予後の関連

  大宮 悟志, 浦出 剛史, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• 右肝葉切除を施行した肝門部領域胆管癌の再考 左側からの切除の可能性

  秋田 真之, 柳本 泰明, 津川 大介, 荒井 啓輔, 吉田 俊彦, 石田 潤, 宗 慎一, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 2, Japanese


• 肝門部領域胆管癌に対する術前門脈塞栓術施行例の検討

  津川 大介, 柳本 泰明, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 石田 潤, 宗 慎一, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 8, Japanese


• 肝外胆管癌切除後の早期再発予測におけるGLIM基準の有用性

  岡副 佑城, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 6, Japanese


• 肝外胆管癌切除後予後因子としてのGLIM基準の有用性に関する検討

  柳本 泰明, 津川 大介, 秋田 真之, 朝倉 力, 三宅 泰一郎, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 木戸 正浩, 外山 博近, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 7, Japanese


• 十二指腸乳頭部癌におけるC-reactive protein to albumin ratio(CAR)の予後への影響

  朝倉 力, 柳本 泰明, 味木 徹夫, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 浦出 剛史, 南野 佳英, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 2, Japanese


• 術前NLR値と胆嚢癌の予後との関連

  上田 泰弘, 柳本 泰明, 味木 徹夫, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 5, Japanese


• 胆道癌における術後静脈血栓症と血漿Dダイマーの関連性の検討

  三宅 泰一郎, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2023, 日本外科学会定期学術集会抄録集, 123回, DP - 3, Japanese


• 肝疾患におけるチーム医療 肝移植患者に対する多職種連携による術前術後管理体制の現状と課題

  荒井 啓輔, 蔵満 薫, 福本 巧

  (一社)日本肝臓学会, Apr. 2023, 肝臓, 64(Suppl.1) (Suppl.1), A220 - A220, Japanese


• 切除不能肝内胆管癌に対する粒子線治療の成績

  山崎 伸明, 寺嶋 千貴, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 吉田 俊彦, 荒井 啓輔, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 味木 徹夫, 徳丸 直郎, 沖本 智昭, 福本 巧

  (一社)日本肝臓学会, Apr. 2023, 肝臓, 64(Suppl.1) (Suppl.1), A416 - A416, Japanese


• 術前骨格筋量減少が肝外胆管癌切除後の長期予後に与える影響に関する観察研究

  岡副 佑城, 柳本 泰明, 津川 大介, 秋田 真之, 荒井 啓輔, 吉田 俊彦, 宗 慎一, 石田 潤, 浦出 剛史, 南野 佳英, 福島 健司, 権 英寿, 小松 昇平, 蔵満 薫, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 福本 巧

  (一財)日本消化器病学会, Mar. 2023, 日本消化器病学会雑誌, 120(臨増総会) (臨増総会), A328 - A328, Japanese


• アルコール性肝硬変に対する肝移植医療の現状と課題

  蔵満 薫, 小松 昇平, 津川 大介, 権 英寿, 福島 健司, 浦出 剛士, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 木戸 正浩, 外山 博近, 福本 巧

  (一財)日本消化器病学会, Mar. 2023, 日本消化器病学会雑誌, 120(臨増総会) (臨増総会), A400 - A400, Japanese


• 食道胃静脈瘤に対するHassab手術が術後肝機能に与える影響についての検討

  福島 健司, 木戸 正浩, 蔵満 薫, 小松 昇平, 権 英寿, 浦出 剛史, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 後藤 直大, 浅利 貞毅, 柳本 泰明, 外山 博近, 味木 徹夫, 福本 巧

  (一財)日本消化器病学会, Mar. 2023, 日本消化器病学会雑誌, 120(臨増総会) (臨増総会), A413 - A413, Japanese


• 保存的治療が可能であった門脈ガス血症の検討

  清水 貴, 柿木 啓太郎, 西山 航平, 中村 浩之, 横尾 拓樹, 佐伯 崇史, 王子 健太郎, 山崎 悠太, 荒井 啓輔, 御井 保彦, 中村 哲, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2023, 兵庫県外科医会会誌, 57, 16 - 16, Japanese


• 当院で経験した成人腸重積症の4例

  中村 浩之, 西山 航平, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 中村 哲, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2023, 兵庫県外科医会会誌, 57, 18 - 18, Japanese


• 初回再発形式からみる肝細胞癌の腫瘍位置と初回再発形式に関する検討

  西尾 公佑, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 吉田 俊彦, 荒井 啓輔, 南野 佳秀, 津川 大介, 後藤 直大, 浅利 貞毅, 味木 徹夫, 福本 巧

  (一社)日本肝臓学会, Oct. 2022, 肝臓, 63(Suppl.3) (Suppl.3), A744 - A744, Japanese


• 進行肝細胞がんに対する新しい治療戦略と集学的治療の明日 神戸大学における肝癌集学的治療の現状

  福本 巧, 小松 昇平, 木戸 正浩, 蔵満 薫, 権 英寿, 福島 健司, 浦出 剛史, 宋 慎一, 外山 博近, 柳本 泰明, 後藤 直大, 津川 大介, 南野 佳英, 荒井 啓輔, 吉田 俊彦

  (一社)日本癌治療学会, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, OWS14 - 7, English


• 肝細胞癌との鑑別が困難であった肝Reactive Lymphoid Hyperplasiaの1例

  西山 航平, 荒井 啓輔, 中村 浩之, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 村田 晃一, 御井 保彦, 上田 泰弘, 柿木 啓太郎, 中村 哲, 岡 成光, 山本 侑毅, 黒田 大介

  症例は70歳代女性で、分枝膵管型IPMNで通院中、画像検査で肝S7に20mm大の腫瘤を指摘された。検査所見では肝胆道系、腫瘍マーカーに異常はなく、腹部造影超音波検査では肝S7に早期相で濃染、後期相でwash outし、肝細胞相で造影欠損を示す16mm大の腫瘤影を認めた。また、腹部造影CTでは肝S7に早期相で濃染、後期相でwash outする病変(23×15mm大)を認め、腹部MRIでは肝細胞癌に典型的な造影パターンを示し、鑑別が困難であった。診断的治療として腫瘍の部分切除を行い、肉眼的所見は皮膜形成を伴わない境界不明瞭な白色病変で、病理組織検査では胚中心を伴う密なリンパ球浸潤を認めたが、異型リンパ球の増殖はみられず、肝Reactive Lymphoid Hyperplasia(RLH)と診断した。

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 29 - 33, Japanese


• 術後神経障害性疼痛を来した骨盤内神経節細胞腫の1例

  荒井 啓輔, 西山 航平, 中村 浩之, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 村田 晃一, 御井 保彦, 上田 泰弘, 柿木 啓太郎, 中村 哲, 岡 成光, 黒田 大介

  症例は17歳女性で、左会陰部痛を主訴とした。骨盤内腫瘍の精査加療目的で紹介受診し、腹部CT検査では子宮背側に低吸収な腫瘍(64mm大)を、腹部MRI検査では仙骨前面にT1で筋肉と等信号、T2で不均一高信号を示し、左第二仙骨神経と接する境界明瞭な腫瘤(最大径62mm大)を認めた。腹腔鏡下後腹膜腫瘍摘出術を行い、腫瘍と連続する神経束計5本を切離した。その結果、摘出標本は均一な充実性腫瘍で、組織診では成熟した神経組織のほか、所々にganglion cellが介在する所見を認め、神経節細胞腫と診断した。術後に左下肢痛の増強やS1からS4領域の知覚低下などを認めたが、神経障害性疼痛の診断で内服加療と運動療法を行い、術後3ヵ月で神経症状は軽減した。

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 34 - 36, Japanese


• 肝細胞癌との鑑別が困難であった肝Reactive Lymphoid Hyperplasiaの1例

  西山 航平, 荒井 啓輔, 中村 浩之, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 村田 晃一, 御井 保彦, 上田 泰弘, 柿木 啓太郎, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 39 - 39, Japanese


• 術後神経障害性疼痛を来した骨盤内神経節細胞腫の1例

  荒井 啓輔, 中村 浩之, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 村田 晃一, 御井 保彦, 上田 泰弘, 柿木 啓太郎, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 41 - 41, Japanese


• 正中弓状靱帯症候群に対して外科的治療を施行した7例

  佐伯 崇史, 柿木 啓太郎, 西山 航平, 王子 健太郎, 横尾 拓樹, 山崎 悠太, 荒井 啓輔, 清水 貴, 御井 保彦, 中村 哲, 岡 成光, 富田 優, 黒田 大介

  正中弓状靱帯圧迫症候群(MALS)に対して術中腹部血管造影を併用した正中弓状靱帯切離術を行った7例(平均年齢67.4歳、男性5例、女性2例)を対象として、外科的治療の安全性と有効性について検討した。術中合併症として1例に術中血管造影時のカテーテルによる腹腔動脈起始部損傷を認めたが、Clavien-Dindo分類grade III以上の術後合併症はなく、術前有症状3例中2例で症状が消失し、5例が腹腔動脈狭窄率90%以下となった。また、膵頭十二指腸動脈瘤(PDAA)合併4例では全例瘤の増大や新規動脈瘤の発生を認めず、1例は瘤径が改善したが、術前狭窄率99%以上の高度狭窄例では画像診断や臨床症状の改善は得られなかった。MALSにおいては、正中弓状靱帯切離によってPDAAの増大や新規形成が抑制され、症状が改善する可能性が示された。

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 62 - 66, Japanese


• 食事指導により再燃を認めなくなった特発性気腹症の1例

  中村 浩之, 荒井 啓輔, 西山 航平, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 御井 保彦, 柿木 啓太郎, 中村 哲, 岡 成光, 黒田 大介

  症例は50歳代女性で、腹痛を主訴とした。5ヵ月前に過食や空えずきを契機に腹痛が生じ、画像検査で腹腔内遊離ガスを認めたが、保存的加療により症状が軽快したエピソードがあった。腹部単純CTでは多量の腹腔内Free airを認め、上部消化管内視鏡検査では穹窿部の胃憩室内部に白苔を認めたが、透視で造影剤漏出はなく、胃憩室穿孔の可能性を考えて腹腔鏡下胃憩室切除術を行った。その結果、腹腔内に混濁腹水や白苔は認めず、病理組織検査で胃憩室と診断された。術後は合併症なく症状改善が得られ、初診時から12ヵ月、24ヵ月後にも同様の腹部症状と腹腔内Free airを認めたが、保存的加療にて軽快した。本症例は気腹症の原因となるような所見がなく、特発性気腹症と診断して1回の食事量を減らし、食事時間をゆっくりにするよう食事指導を行った結果、以後、腹部症状の再燃を認めていない。

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 70 - 72, Japanese


• 正中弓状靱帯症候群に対して外科的治療を施行した7例

  佐伯 崇史, 西山 航平, 中村 浩之, 王子 健太郎, 横尾 拓樹, 山崎 悠太, 清水 貴, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 中村 哲, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 81 - 81, Japanese


• 食事指導により再燃を認めなくなった特発性気腹症の1例

  中村 浩之, 荒井 啓輔, 西山 航平, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 御井 保彦, 柿木 啓太郎, 中村 哲, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2022, 兵庫県外科医会会誌, 56, 83 - 83, Japanese


• CRT後の難治性食道狭窄に対する鏡視下食道バイパス術(Postlethwait法)の試み

  横尾 拓樹, 中村 哲, 西山 航平, 王子 健太郎, 佐伯 崇史, 山崎 悠太, 清水 貴, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 押切 太郎, 掛地 吉弘, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2021, 日本内視鏡外科学会雑誌, 26(7) (7), MO251 - 4, Japanese


• 食道癌術後吻合部通過障害に対する仰臥位左胸腔鏡を併用した再建経路変更術の1例

  西山 航平, 中村 哲, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 山崎 悠太, 清水 貴, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2021, 日本内視鏡外科学会雑誌, 26(7) (7), MO253 - 3, Japanese


• 肝硬変患者に対する腹腔鏡下胃切除術の工夫(Laparoscopic gastrectomy in patients with liver cirrhosis)

  村田 晃一, 黒田 大介, 中村 浩之, 佐伯 崇史, 王子 健太郎, 岡本 柊志, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 岡 成光

  (一社)日本胃癌学会, Mar. 2021, 日本胃癌学会総会記事, 93回, 320 - 320, English


• 食道癌手術における再建に対する当院での工夫 腹腔鏡下胸骨後経路、胃管再建、胃瘻造設術

  村田 晃一, 黒田 大介, 王子 健太郎, 横尾 拓樹, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 御井 保彦, 岡 成光

  (一社)日本消化器外科学会, Dec. 2020, 日本消化器外科学会総会, 75回, P008 - 6, Japanese


• 食道inflammatory myofibroblastic tumorの手術経験

  岡本 柊志, 村田 晃一, 王子 健太郎, 横尾 拓樹, 藤中 亮輔, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 黒田 大介

  (一社)日本消化器外科学会, Dec. 2020, 日本消化器外科学会総会, 75回, P027 - 3, Japanese


• 食道癌術後に気管食道瘻を来した2症例

  村田 晃一, 黒田 大介, 佐伯 崇史, 横尾 拓樹, 王子 健太郎, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 御井 保彦, 柿木 啓太郎

  (NPO)日本食道学会, Dec. 2020, 日本食道学会学術集会プログラム・抄録集, 74回, 337 - 337, Japanese


• 門脈合併切除を伴う膵頭十二指腸切除術を行った膵過誤腫の1例

  宇井 更, 荒井 啓輔, 中村 浩之, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 岡本 柊志, 村田 晃一, 御井 保彦, 柿木 啓太郎, 岡成 光, 黒田 大介

  日本臨床外科学会, Oct. 2020, 日本臨床外科学会雑誌, 81(増刊) (増刊), 582 - 582, Japanese


• 手術手技 助手のアシストを積極的に使用したda Vinci Si Surgical Systemによるロボット支援下直腸切除術の腹部操作における工夫

  御井 保彦, 藤中 亮輔, 岡本 柊志, 荒井 啓輔, 柿木 啓太郎, 黒田 大介

  金原出版(株), Aug. 2020, 手術, 74(9) (9), 1369 - 1373, Japanese


• 当院における正中弓状靱帯症候群に対する手術症例の検討

  藤中 亮輔, 岡本 柊志, 荒井 啓輔, 音羽 泰則, 村田 晃一, 御井 保彦, 柿木 啓太郎, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2020, 兵庫県外科医会会誌, 54, 25 - 25, Japanese


• 当院における食道裂孔ヘルニアに対する腹腔鏡下手術症例の検討

  岡本 柊志, 音羽 泰則, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 岡 成光, 黒田 大介

  兵庫県外科医会, Mar. 2020, 兵庫県外科医会会誌, 54, 25 - 26, Japanese


• 当院における食道裂孔ヘルニアに対する腹腔鏡下手術症例の検討

  岡本 柊志, 音羽 泰則, 王子 健太郎, 佐伯 崇史, 横尾 拓樹, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 岡 成光, 黒田 大介

  臨床症状が強い食道裂孔ヘルニアに対して腹腔鏡下手術を行った3例(88歳女、91歳女、75歳女)の手術術式・成績を報告した。手術は開脚位・5ポートで行い、裂孔部より胸腔内に脱出している臓器を確認した上で脱出臓器を腹腔内に還納し、術後の消化管狭窄を予防するために術中内視鏡を行いながらヘルニア門を縫縮した。その後、裂孔部にメッシュをステープラで固定し、最後に胃底部後壁を横隔膜脚に固定して手術を終了した。3例はいずれも内科的治療に対して難治性であったため、メッシュ固定を含めた腹腔鏡下食道裂孔修復術を行った。術後は3例とも逆流性症状が改善し、術中・術後合併症なく経過した。

  兵庫県外科医会, Mar. 2020, 兵庫県外科医会会誌, 54, 9 - 12, Japanese


• 術前診断に苦慮した胃リンパ球浸潤癌のリンパ節転移の1症例

  村田 晃一, 黒田 大介, 佐伯 崇史, 横尾 拓樹, 王子 健太郎, 藤中 亮輔, 荒井 啓輔, 御井 保彦, 柿木 啓太郎, 岡 成光

  (一社)日本胃癌学会, Mar. 2020, 日本胃癌学会総会記事, 92回, 386 - 386, Japanese


• 反回神経麻痺軽減を目指した食道癌手術における上縦隔郭清の工夫

  村田 晃一, 黒田 大介, 藤中 亮輔, 荒井 啓輔, 御井 保彦, 柿木 啓太郎

  (一社)日本内視鏡外科学会, Dec. 2019, 日本内視鏡外科学会雑誌, 24(7) (7), SF004 - 1, Japanese


• 膵頭部癌との鑑別が困難であった自己免疫性膵炎の1切除例

  藤中 亮輔, 柿木 啓太郎, 王子 健太郎, 横尾 拓樹, 佐伯 崇史, 岡本 柊志, 荒井 啓輔, 村田 晃一, 御井 保彦, 黒田 大介

  日本消化器病学会-近畿支部, Oct. 2019, 日本消化器病学会近畿支部例会プログラム・抄録集, 111回, 90 - 90, Japanese


• 正常肝を背景とし胆道出血を契機に発症した肝細胞癌(HCC)の1例

  日笠 雄太, 森川 輝久, 井上 裕太, 二井 諒子, 三木 美香, 阿部 哲之, 家本 孝雄, 佐々木 綾香, 田中 克英, 吉江 智郎, 大瀬 貴之, 佐貫 毅, 荒井 啓輔, 黒田 大介

  日本消化器病学会-近畿支部, Oct. 2019, 日本消化器病学会近畿支部例会プログラム・抄録集, 111回, 103 - 103, Japanese


• 進行食道癌に対する手術加療を目的としたDCF療法

  村田 晃一, 黒田 大介, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光

  (株)癌と化学療法社, Aug. 2019, 癌と化学療法, 46(8) (8), 1337 - 1339, Japanese


• 当院における高齢者胃癌手術成績の検討

  荒井 啓輔, 岡本 柊志, 藤中 亮輔, 音羽 泰則, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本消化器外科学会, Jul. 2019, 日本消化器外科学会総会, 74回, P24 - 3, Japanese


• 高齢で抗凝固薬内服中の急性胆嚢炎に対する腹腔鏡下胆嚢摘出術の安全性についての検討

  王子 健太郎, 音羽 泰則, 荒井 啓輔, 岡本 柊志, 藤中 亮輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本消化器外科学会, Jul. 2019, 日本消化器外科学会総会, 74回, P212 - 2, Japanese


• 門脈輪状膵を伴った膵頭部IPMNに膵頭十二指腸切除術を施行した1例

  藤中 亮輔, 柿木 啓太郎, 岡本 柊志, 荒井 啓輔, 音羽 泰則, 村田 晃一, 御井 保彦, 万井 真理子, 黒田 大介

  (一社)日本消化器外科学会, Jul. 2019, 日本消化器外科学会総会, 74回, P237 - 3, Japanese


• 閉塞性大腸癌に対する自己拡張型金属ステントとイレウスチューブの安全性、有用性についての比較検討

  佐伯 崇史, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本消化器外科学会, Jul. 2019, 日本消化器外科学会総会, 74回, P148 - 5, Japanese


• 当院における大腸癌Stage IIの術後補助化学療法の妥当性の検討

  横尾 拓樹, 音羽 泰則, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本消化器外科学会, Jul. 2019, 日本消化器外科学会総会, 74回, P89 - 1, Japanese


• 当院での食道癌手術における再建の工夫 腹腔鏡下胸骨後経路、胃管再建、胃瘻造設術

  村田 晃一, 黒田 大介, 中村 浩之, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 御井 保彦, 柿木 啓太郎, 岡 成光

  (NPO)日本食道学会, Jun. 2019, 日本食道学会学術集会プログラム・抄録集, 73回, 132 - 132, Japanese


• 胃管癌に対する胸腔鏡下幽門側胃管切除術の経験

  中村 浩之, 黒田 大介, 岡 成光, 柿木 啓太郎, 御井 保彦, 村田 晃一, 音羽 泰則, 荒井 啓輔, 藤中 亮輔, 岡本 柊志

  (NPO)日本食道学会, Jun. 2019, 日本食道学会学術集会プログラム・抄録集, 73回, 279 - 279, Japanese


• 急性胆嚢炎発症後72時間以内の手術加療を推奨する妥当性の検討

  王子 健太郎, 音羽 泰則, 荒井 啓輔, 岡本 柊志, 藤中 亮輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本外科学会, Apr. 2019, 日本外科学会定期学術集会抄録集, 119回, RS - 7, Japanese


• 高齢者胃癌患者に対してリンパ節郭清範囲が及ぼす影響についての検討

  音羽 泰則, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本外科学会, Apr. 2019, 日本外科学会定期学術集会抄録集, 119回, PS - 3, Japanese


• 急性虫垂炎に対する腹腔鏡下虫垂切除術での切除方法による合併症発症の比較

  岡本 柊志, 音羽 泰則, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本外科学会, Apr. 2019, 日本外科学会定期学術集会抄録集, 119回, PS - 8, Japanese


• 当院での高齢者大腸癌手術の短期成績

  佐伯 崇史, 音羽 泰則, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本外科学会, Apr. 2019, 日本外科学会定期学術集会抄録集, 119回, PS - 3, Japanese


• 当院における腹腔鏡下胃全摘術後の吻合についての後方視的検討

  村田 晃一, 黒田 大介, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光

  (一社)日本外科学会, Apr. 2019, 日本外科学会定期学術集会抄録集, 119回, PS - 8, Japanese


• 当院での高齢者胃癌手術の短期成績

  音羽 泰則, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 岡 成光, 黒田 大介

  (一社)日本胃癌学会, Feb. 2019, 日本胃癌学会総会記事, 91回, 436 - 436, Japanese


• 当院における胃腫瘍に対する腹腔鏡内視鏡合同手術LECS関連手技の経験

  万井 真理子, 荒井 啓輔, 音羽 泰則, 村田 晃一, 御井 保彦, 柿木 啓太郎, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS1 - 6, Japanese


• 治療アプローチの違いによる急性胆嚢炎の術後短期成績の検討

  音羽 泰則, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS65 - 5, Japanese


• 腹腔鏡下胃全摘術の食道空腸吻合に対するOverlap法の導入と手術成績

  村田 晃一, 黒田 大介, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 御井 保彦, 柿木 啓太郎, 万井 真理子

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS113 - 3, Japanese


• 急性虫垂炎に対する腹腔鏡下虫垂切除術での切除方法による合併症発症の比較

  岡本 柊志, 音羽 泰則, 藤中 亮輔, 荒井 啓輔, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS126 - 4, Japanese


• 当院におけるロボット支援胃切除術の導入と現状

  黒田 大介, 村田 晃一, 万井 真理子, 藤中 亮輔, 音羽 泰則, 荒井 啓輔, 岡本 柊志, 御井 保彦, 柿木 啓太郎

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS152 - 4, Japanese


• 腹腔鏡下直腸癌手術における大血管損傷に対する縫合止血術

  御井 保彦, 岡本 柊志, 藤中 亮輔, 荒井 啓輔, 音羽 泰則, 村田 晃一, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), OS176 - 1, Japanese


• 直腸脱に対する腹腔鏡下直腸固定術の検討

  藤中 亮輔, 岡本 柊志, 荒井 啓輔, 音羽 泰則, 村田 晃一, 御井 保彦, 柿木 啓太郎, 万井 真理子, 黒田 大介

  (一社)日本内視鏡外科学会, Dec. 2018, 日本内視鏡外科学会雑誌, 23(7) (7), DP144 - 3, Japanese


• 術前DIC-CTおよび術中胆道造影により副交通胆管枝を確認し安全に腹腔鏡下胆嚢摘出術を施行した胆嚢結石症の1例

  荒井 啓輔, 斎藤 正樹, 木戸 正浩

  医学図書出版(株), Apr. 2018, 胆と膵, 39(4) (4), 373 - 376, Japanese


• 高度進行肝癌に対する肝切除とPIHPを組み合わせた治療戦略

  田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 粟津 正英, 権 英寿, 荒井 啓輔, 田井 謙太郎, 保原 祐樹, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 楠 信也, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2018, 日本外科学会定期学術集会抄録集, 118回, 1229 - 1229, Japanese


• 肝細胞癌門脈腫瘍栓の進展速度に関わる因子に関する後ろ向き研究

  権 英寿, 木戸 正浩, 田中 基文, 木下 秘我, 小松 昇平, 津川 大介, 粟津 正英, 荒井 啓輔, 田井 謙太郎, 保原 祐樹, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 味木 徹夫, 福本 巧

  (一社)日本外科学会, Apr. 2018, 日本外科学会定期学術集会抄録集, 118回, 1664 - 1664, Japanese


• C型慢性肝炎に対するDAA治療 肝細胞癌根治切除例の検討

  田井 謙太郎, 田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 粟津 正英, 権 英寿, 中馬 正志, 荒井 啓輔, 保原 祐樹, 白川 幸代, 山下 博成, 南野 佳英, 津川 大介, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 味木 徹夫, 福本 巧

  (一財)日本消化器病学会, Mar. 2018, 日本消化器病学会雑誌, 115(臨増総会) (臨増総会), A310 - A310, Japanese


• 当院における腹腔鏡下肝切除の定型化と適応拡大への工夫

  津川 大介, 木戸 正浩, 田中 基文, 木下 秘我, 小松 昇平, 粟津 正英, 権 英寿, 荒井 啓輔, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 味木 徹夫, 福本 巧

  (一社)日本内視鏡外科学会, Dec. 2017, 日本内視鏡外科学会雑誌, 22(7) (7), EP182 - 04, Japanese


• 炎症性疾患の新規診断技術の開発

  山本 龍一, 荒井 啓輔, 福本 巧, 今石 浩正

  生命科学系学会合同年次大会運営事務局, Dec. 2017, 生命科学系学会合同年次大会, 2017年度, [2P - 1122], Japanese


• C型慢性肝炎に対するDAA治療 肝細胞癌根治切除例の検討

  田井 謙太郎, 田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 粟津 正英, 権 英寿, 中馬 正志, 荒井 啓輔, 保原 祐樹, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 楠 信也, 福本 巧

  (株)医薬情報研究所, Nov. 2017, 新薬と臨牀, 66(11) (11), 1438 - 1438, Japanese


• 脳死肝移植後の虚血性胆管障害の治療経過中に肝門部胆管癌を発症した一例

  田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 荒井 啓輔, 福本 巧

  (一社)日本移植学会, Nov. 2017, 移植, 52(4-5) (4-5), 442 - 443, Japanese


• 脳死肝移植におけるサイズミスマッチグラフトに対する静脈吻合の工夫

  木戸 正浩, 田中 基文, 木下 秘我, 小松 昇平, 津川 大介, 荒井 啓輔, 田井 謙太郎, 保原 祐樹, 福本 巧

  (一社)日本移植学会, Nov. 2017, 移植, 52(4-5) (4-5), 459 - 459, Japanese


• 安全正確な系統的肝癌手術 当施設における肝前/後区域切除術での検討

  田井 謙太郎, 木戸 正浩, 田中 基文, 木下 秘我, 小松 昇平, 津川 大介, 粟津 正英, 権 英寿, 荒井 啓輔, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 味木 徹夫, 福本 巧

  日本臨床外科学会, Oct. 2017, 日本臨床外科学会雑誌, 78(増刊) (増刊), 412 - 412, Japanese


• 術中Shear Wave Elastgraphyによる肝硬度測定と肝繊維化診断

  荒井 啓輔, 田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 椋棒 英世, 寺井 祥雄, 松本 拓, 浅利 貞毅, 外山 博近, 楠木 信也, 味木 徹夫, 福本 巧

  (一財)日本消化器病学会, Sep. 2017, 日本消化器病学会雑誌, 114(臨増大会) (臨増大会), A736 - A736, Japanese


• 当院におけるアルコール性肝硬変に対する肝移植患者の社会復帰の現状

  津川 大介, 木戸 正浩, 田中 基文, 山根 秘我, 小松 昇平, 粟津 正英, 権 英寿, 荒井 啓輔, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 味木 徹夫, 福本 巧

  (一社)日本移植学会, Aug. 2017, 移植, 52(総会臨時) (総会臨時), 338 - 338, Japanese


• 当院の脳死肝移植チームにおける現状から見えてきたもの

  荒井 啓輔, 木戸 正浩, 田中 基文, 山根 秘我, 小松 昇平, 津川 大介, 粟津 正英, 権 英寿, 椋棒 英世, 寺井 祥雄, 外山 博近, 上野 公彦, 楠 信也, 味木 徹夫, 福本 巧

  (一社)日本移植学会, Aug. 2017, 移植, 52(総会臨時) (総会臨時), 381 - 381, Japanese


• ドナーを増やすために移植医が出来ること

  木戸 正浩, 田中 基文, 山根 秘我, 小松 昇平, 津川 大介, 外山 博近, 寺井 祥雄, 椋棒 英世, 粟津 正英, 権 英寿, 山下 博成, 荒井 啓輔, 福本 巧

  (一社)日本移植学会, Aug. 2017, 移植, 52(総会臨時) (総会臨時), 405 - 405, Japanese


• 肝切除におけるシミュレーションおよびナビゲーション技術の最前線 肝切除における術中超音波を用いた胆道ナビゲーションサージャリーの現状と将来展望

  浦出 剛史, 福本 巧, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 荒井 啓輔, 外山 博近, 味木 徹夫, 黒田 大介, 具 英成

  (一社)日本外科学会, Apr. 2017, 日本外科学会定期学術集会抄録集, 117回, SY - 3, Japanese


• C型慢性肝炎に対するDAA治療 肝細胞癌根治切除例の検討

  荒井 啓輔, 田中 基文, 福本 巧, 木戸 正浩, 木下 秘我, 蔵満 薫, 小松 昇平, 津川 大介, 吉田 俊彦, 寺井 祥雄, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 楠 信也, 味木 徹夫, 具 英成

  (一財)日本消化器病学会, Mar. 2017, 日本消化器病学会雑誌, 114(臨増総会) (臨増総会), A367 - A367, Japanese


• 下大静脈浸潤肝癌に対する肝切除

  荒井 啓輔, 木戸 正浩, 福本 巧, 味木 徹夫, 楠 信也, 外山 博近, 武部 敦志, 浅利 貞毅, 田中 基文, 後藤 直大, 松本 拓, 蔵満 薫, 寺井 祥雄, 木下 秘我, 具 英成

  (一社)日本肝胆膵外科学会, Jun. 2016, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 28回, 427 - 427, Japanese


• 進行肝細胞癌に対する術前化学療法としての経皮的肝灌流化学療法(PIHP)

  田中 基文, 福本 巧, 木戸 正浩, 木下 秘我, 蔵満 薫, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 寺井 祥雄, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 楠 信也, 味木 徹夫, 具 英成

  (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PS - 5, Japanese


• 硬変肝を背景とした肝細胞癌に対する肝切除の意義

  吉田 俊彦, 武部 敦志, 福本 巧, 楠 信也, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 宗 慎一, 荒井 啓輔, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成

  (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PS - 3, Japanese


• 進行肝癌(門脈内腫瘍栓、両葉多発)に対する治療戦略の最前線 多発進行肝癌に対する集学的治療

  木戸 正浩, 福本 巧, 武部 敦志, 田中 基文, 木下 秘我, 蔵満 薫, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成

  (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PD - 1, Japanese


• Minocycline注入療法施行7ヵ月後に破裂をきたした巨大肝嚢胞の1例

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 門馬 浩行, 岸 真示, 衣笠 章一

  64歳女。巨大肝嚢胞に対するminocycline注入療法施行7ヵ月後に突然腹痛が出現し、精査加療目的に当科入院となった。造影CTにて肝右葉に直径17cm大の巨大嚢胞を認め、背側に造影剤の漏出を認めたことから、肝嚢胞破裂と診断し緊急腹腔鏡下肝嚢胞開窓術を施行した。術後経過は良好で、術後6日目に退院となった。術後1ヵ月のCTでは肝嚢胞の縮小がみられた。

  (株)南江堂, Mar. 2016, 外科, 78(3) (3), 337 - 340, Japanese


• 膨潤腹腔鏡手術の手技と利点 膨潤麻酔を併用したTAPPの経験

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 門馬 浩行, 岸 真示, 衣笠 章一, 中村 毅

  (一社)日本内視鏡外科学会, Dec. 2015, 日本内視鏡外科学会雑誌, 20(7) (7), WS28 - 2, Japanese


• 困難症例への腹腔鏡下鼡径ヘルニア手術 Composit mesh、膨潤麻酔の有用性

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 渋谷 尚樹, 田淵 智美, 門馬 浩行, 岸 真示, 辰巳 嘉章, 衣笠 章一, 光辻 理顕, 福岡 正人, 中村 毅, 橘 史朗

  (一社)日本内視鏡外科学会, Dec. 2015, 日本内視鏡外科学会雑誌, 20(7) (7), OS4 - 1, Japanese


• 当院における進行直腸癌に対する腹腔鏡下側方郭清術

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 門馬 浩行, 岸 真示, 衣笠 章一, 渋谷 尚樹, 田淵 智美, 辰巳 嘉章, 箕畑 順也, 光辻 理顕, 福岡 正人, 中村 毅, 橘 史朗

  (一社)日本内視鏡外科学会, Dec. 2015, 日本内視鏡外科学会雑誌, 20(7) (7), OS68 - 7, Japanese


• 臨床経験 Shoelace darn repair法を用いた腹壁瘢痕ヘルニア修復術・人工肛門閉鎖術

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 門馬 浩行, 衣笠 章一, 中村 毅

  Shoelace darn repair法を用いて、腹壁瘢痕ヘルニア修復術を4例に、人工肛門閉鎖術を5例に行った。対象は男5例・女4例で、年齢42～83歳であった。感染症は4例で認めたが、うち3例は切開排膿・洗浄、1例は抗生物質投与にて改善した。感染例、非感染例ともに術後再発は認めず、良好に経過している。

  (株)南江堂, Nov. 2015, 外科, 77(11) (11), 1271 - 1274, Japanese


• 肝胆道手術におけるイノベーション ソナゾイド術中超音波下胆道造影を用いた胆道ナビゲーション

  荒井 啓輔, 福本 巧, 田中 基文, 木戸 正浩, 武部 敦志, 蔵満 薫, 木下 秘我, 松本 拓, 宋 慎一, 吉田 俊彦, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成

  日本臨床外科学会, Oct. 2015, 日本臨床外科学会雑誌, 76(増刊) (増刊), 580 - 580, Japanese


• 若手移植医が考える、移植医療の未来 肝移植医養成における現状と課題

  蔵満 薫, 福本 巧, 木戸 正浩, 武部 敦志, 田中 基文, 木下 秘我, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成

  (一社)日本移植学会, Sep. 2015, 移植, 50(総会臨時) (総会臨時), 191 - 191, Japanese


• 長期生存を得たpNET肝転移の3例

  荒井 啓輔, 福本 巧, 木戸 正浩, 武部 敦志, 田中 基文, 蔵満 薫, 木下 秘我, 外山 博近, 味木 徹夫, 具 英成

  (一社)日本消化器外科学会, Jul. 2015, 日本消化器外科学会総会, 70回, RS - 5, Japanese


• Shoelace Darn Repair法を用いた腹壁瘢痕ヘルニア修復術・人工肛門閉鎖術の経験

  永田 真知子, 荒井 啓輔, 門馬 浩之, 阿部 紘一郎, 加藤 祥穂, 岸 真示, 衣笠 章一, 常見 幸三, 中村 毅

  日本臨床外科学会, Oct. 2014, 日本臨床外科学会雑誌, 75(増刊) (増刊), 656 - 656, Japanese


• 脾臓摘出術により炎症所見が改善したSclerosing angiomatoid nodular transformationの1例

  瀬戸 悠太郎, 衣笠 章一, 荒井 啓輔, 永田 真知子, 加藤 祥穂, 門馬 浩行, 阿部 紘一郎, 岸 真示, 常見 幸三, 中村 毅, 藤本 昌代, 田代 敬

  日本臨床外科学会, Oct. 2014, 日本臨床外科学会雑誌, 75(増刊) (増刊), 850 - 850, Japanese


• 急性十二指腸潰瘍穿孔に対し腹腔鏡下十二指腸潰瘍穿孔縫合術、大網被覆術を行った1例

  荒井 啓輔, 高橋 毅, 中村 毅, 衣笠 章一, 阿部 紘一郎, 永田 真知子

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 439 - 439, Japanese


• 急性胆嚢炎に対し腹腔鏡下胆嚢摘出術を施行した1例

  荒井 啓輔, 高橋 毅, 中村 毅, 衣笠 章一, 阿部 紘一郎, 永田 真知子

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 443 - 443, Japanese


• 腹腔鏡下腹壁瘢痕ヘルニア修復術の経験

  永田 真知子, 荒井 啓輔, 門馬 浩行, 加藤 祥穂, 阿部 紘一郎, 岸 真示, 衣笠 章一, 常見 幸三, 中村 毅

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 447 - 447, Japanese


• 卒後8年目、TAPPによる技術認定医取得

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 衣笠 章一, 中村 毅

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 545 - 545, Japanese


• 2度の開腹既往のある胆嚢結石症患者に対して非定型的視野下に腹腔鏡下胆嚢摘出術を行った1例

  高橋 毅, 荒井 啓輔

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 601 - 601, Japanese


• 腹腔鏡下腹壁瘢痕ヘルニア根治術の導入(v-locによるヘルニア門の縫合閉鎖)

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 衣笠 章一, 中村 毅

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 699 - 699, Japanese


• 約60年前胃下垂にて胃固定術を受けた患者に対し腹腔鏡下幽門側胃切除術を施行した1例

  永田 真知子, 荒井 啓輔, 門馬 浩行, 加藤 祥穂, 阿部 紘一郎, 岸 真示, 衣笠 章一, 常見 幸三, 中村 毅

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 824 - 824, Japanese


• 慢性経過を辿った両側閉鎖孔ヘルニアに対し腹腔鏡下修復術を行った1例

  荒井 啓輔, 高橋 毅

  (一社)日本内視鏡外科学会, Oct. 2014, 日本内視鏡外科学会雑誌, 19(7) (7), 840 - 840, Japanese


• 腹腔鏡下核出術を行った食道胃接合部leiomyomatosisの1例

  衣笠 章一, 丸中 淳, 永田 真知子, 荒井 啓輔, 阿部 紘一郎, 常見 幸三, 中村 毅, 田代 敬

  (NPO)日本食道学会, Jul. 2014, 日本食道学会学術集会プログラム・抄録集, 68回, 163 - 163, Japanese


• Trousseau症候群の2例

  衣笠 章一, 永田 真知子, 荒井 啓輔, 加藤 祥穂, 阿部 紘一郎, 常見 幸三, 中村 毅

  (一社)日本癌治療学会, Jun. 2014, 日本癌治療学会誌, 49(3) (3), 2733 - 2733, Japanese


• Paritex Composite Meshによる腹腔鏡下傍ストマヘルニア根治術(Sugabaker法)を施行した一例

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 殿元 康仁, 衣笠 章一, 高松 学, 常見 幸三, 中村 毅

  (一社)日本内視鏡外科学会, Nov. 2013, 日本内視鏡外科学会雑誌, 18(7) (7), 411 - 411, Japanese


• V-Locクロージャーデバイスを用いた完全鏡視下胃全摘、胃切除の2例

  荒井 啓輔, 阿部 紘一郎, 中村 毅, 常見 幸三, 衣笠 章一, 殿元 康仁, 永田 真知子

  (一社)日本内視鏡外科学会, Nov. 2013, 日本内視鏡外科学会雑誌, 18(7) (7), 561 - 561, Japanese


• 当院における完全鏡視下腹腔鏡下胃全摘術の再建法(FEEA法の導入)

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 殿元 康仁, 衣笠 章一, 常見 幸三, 中村 毅

  (一社)日本内視鏡外科学会, Nov. 2013, 日本内視鏡外科学会雑誌, 18(7) (7), 582 - 582, Japanese


• 緊急で腹腔鏡下開窓術を施行した巨大肝嚢胞破裂の1例

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 殿元 康仁, 衣笠 章一, 常見 幸三, 中村 毅

  (一社)日本内視鏡外科学会, Nov. 2013, 日本内視鏡外科学会雑誌, 18(7) (7), 713 - 713, Japanese


• 腹腔鏡下横行結腸切除術の1例

  阿部 紘一郎, 永田 真知子, 荒井 啓輔, 衣笠 章一, 殿元 康仁, 常見 幸三, 中村 毅

  日本臨床外科学会, Oct. 2013, 日本臨床外科学会雑誌, 74(増刊) (増刊), 660 - 660, Japanese


• 術後再発を認めた巨大肝嚢胞に対し腹腔鏡下開窓術を行った1例

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 殿元 康仁, 衣笠 章一, 常見 幸三, 中村 毅

  日本臨床外科学会, Oct. 2013, 日本臨床外科学会雑誌, 74(増刊) (増刊), 735 - 735, Japanese


• 低線量肺がんCT検診画像の精度管理 施設認定制度を見据えて

  村松 禎久, 荒井 美紀, 石垣 陸太, 新井 知大, 野村 恵一, 藤井 啓輔, 佐々木 徹, 花井 耕造, 待鳥 詔洋, 森山 紀之

  (NPO)日本CT検診学会, Jul. 2013, CT検診, 20(2) (2), 70 - 76, Japanese


• 術前イマチニブ投与にて肛門括約筋温存手術を行えた直腸GISTの一例

  永田 真知子, 荒井 啓輔, 阿部 紘一郎, 殿元 康仁, 高松 学, 衣笠 章一, 常見 幸三, 中村 毅, 田代 敬

  (一社)日本消化器外科学会, Jul. 2013, 日本消化器外科学会総会, 68回, P - 9, Japanese


• 印環細胞癌を伴ったlong segment Barrett食道癌の1例

  衣笠 章一, 荒井 啓輔, 永田 真知子, 阿部 紘一郎, 殿元 康仁, 高松 学, 常見 幸三, 中村 毅, 田代 敬

  (NPO)日本食道学会, Jun. 2013, 日本食道学会学術集会プログラム・抄録集, 67回, 322 - 322, Japanese


• FDG-PET検査が陽性であった残胃癌の一例

  荒井 啓輔, 中村 毅, 高松 学, 永田 真知子, 阿部 紘一郎, 殿元 康仁, 衣笠 章一, 常見 幸三

  (一社)日本胃癌学会, Feb. 2013, 日本胃癌学会総会記事, 85回, 387 - 387, Japanese


• 腸重積を合併した進行盲腸癌腹腔鏡手術の1例

  荒井 啓輔, 木下 秘我, 永田 真知子, 阿部 紘一郎, 殿元 康仁, 高松 学, 衣笠 章一, 常見 幸三, 中村 毅, 石川 泰

  (一社)日本内視鏡外科学会, Dec. 2012, 日本内視鏡外科学会雑誌, 17(7) (7), 479 - 479, Japanese


• FOLFOX+セツキシマブによる術前治療で膀胱温存しえた結腸膀胱瘻形成S状結腸癌の1例

  衣笠 章一, 木下 秘我, 殿元 康仁, 三宅 美穂, 荒井 啓輔, 常見 幸三, 中村 毅

  (一社)日本癌治療学会, Oct. 2012, 日本癌治療学会誌, 47(3) (3), 1566 - 1566, Japanese


• 杙創による膀胱直腸損傷に対し、内視鏡的治療を行い軽快した1例

  阿部 紘一郎, 中村 毅, 常見 幸三, 衣笠 章一, 高松 学, 殿元 康仁, 荒井 啓輔, 永田 真知子, 松本 綾希子

  日本臨床外科学会, Oct. 2012, 日本臨床外科学会雑誌, 73(増刊) (増刊), 536 - 536, Japanese


• 内視鏡的止血術後に根治手術を行なった出血性十二指腸GISTの一例

  荒井 啓輔, 衣笠 章一, 阿部 紘一郎, 永田 真知子, 殿元 康仁, 高松 学, 常見 幸三, 中村 毅, 松本 綾希子, 石川 泰

  日本臨床外科学会, Oct. 2012, 日本臨床外科学会雑誌, 73(増刊) (増刊), 701 - 701, Japanese


• 原発性副甲状腺機能亢進症を発症した副甲状腺嚢腫の一例

  永田 真知子, 衣笠 章一, 荒井 啓輔, 阿部 紘一郎, 殿元 康仁, 松本 綾希子, 高松 学, 常見 幸三, 中村 毅, 田代 敬

  日本臨床外科学会, Oct. 2012, 日本臨床外科学会雑誌, 73(増刊) (増刊), 901 - 901, Japanese


• 神経内分泌細胞癌と高分化型腺癌の同時性多発胃癌の1例

  殿元 康仁, 永田 真知子, 荒井 啓輔, 阿部 紘一郎, 高松 学, 衣笠 章一, 常見 幸三, 中村 毅, 田代 敬

  日本臨床外科学会, Oct. 2012, 日本臨床外科学会雑誌, 73(増刊) (増刊), 989 - 989, Japanese


• 胃癌による癌性腹膜炎患者に対し化学療法併用の経腸栄養管理を行った一例

  三宅 美穂, 衣笠 章一, 荒井 啓輔, 森川 香, 高橋 千恵, 下浦 佳之, 山下 扶美, 木下 秘我, 殿元 康仁, 常見 幸三, 中村 毅

  (株)ジェフコーポレーション, Jan. 2012, 静脈経腸栄養, 27(1) (1), 566 - 566, Japanese

• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• A Case of Successful Conversion Hepatectomy Following Durvalumab plus Tremelimumab Therapy under Nasogastric Feeding for Advanced Vp4 Hepatocellular Carcinoma

  Sano H, Fukushima K, Komatsu S, Kido M, Urade T, So S, Yoshida T, Tai K, Arai K, Iguchi K, Nanno Y, Asari S, Yanagimoto H, Kodama T, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Impact of tumor size on liver regeneration after hepatectomy

  Takimoto D, Komatsu S, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Fujinaka R, Nanno Y, Asari S, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Prognostic and predictive value of lymphocyte-to-monocyte transition in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab

  Omori M, Komatsu S, Tada T, ishihara N, Matsuura T, Ueshima E, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Evaluation of Nutritional Risk Assessment Methods for Hepatectomy in Hepatocellular Carcinoma

  Oji K, Urade T, Kido M, Komatsu S, Fukushima K, Yoshida T, Tai K, Arai K, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Outcomes and Indications of Curative Conversion Therapy After Immunotherapy

  Tai K, Komatsu S, Tada T, Matsuura T, Ueshima E, Omori M, Ishihara N, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Impact of Initial Hepatectomy With Hilar Manipulation on Short-Term Outcomes of Repeat Hepatectomy for Recurrent Liver Cancer

  Arai K, Gon H, Komatsu S, Fukushima K, Kido M, Urade T, So S, Yoshida T, Tai K, Akita M, Yanagimoto H, Mizumoto T, Ishida J, Nanno Y, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Treatment strategy for Colorectal liver metastases based on liver resection and the benefit of preoperative chemotherapy

  Yoshida T, Komatsu S, Kido M, Gon H, Fukushima K, Urade T, So S, Tai K, Arai K, Iguchi K, Mizumoto T, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Laparoscopic right posterior sectionectomy using the anterior approach for huge hepatocellular carcinoma

  Urade T, Kido M, Komatsu S, Fukushima K, So S, Yoshida T, Tai K, Arai K, Iguchi K, Mizumoto T, Ishida J, Nanno Y, Asari S, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Impact of Post-Hepatectomy Liver Failure on Long-Term Liver Function and Prognosis in Patients with Hepatocellular Carcinoma

  Fukushima K, Komatsu S, Kido M, Urade T, So S, Yoshida T, Tai K, Arai K, Iguchi K, Mizumoto T, Ishida J, Nanno Y, Asari S, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Poster presentation


• Prognostic and predictive value of lymphocyte-to-monocyte transition in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab

  Omori M, Komatsu S, Tada T, ishihara N, Matsuura T, Ueshima E, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Fukumoto T

  The 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2025), Jul. 2025, English, International conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Poster presentation


• Comparison of short-term outcomes between open and laparoscopic surgery for multiple liver resections

  Takimoto D, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  ILLS2025, Jun. 2025, English, International conference

  Poster presentation


• Impact of malnutrition on short- and long-term outcomes in laparoscopic liver resection for hepatocellular carcinoma

  Oji K, Urade T, Kido M, Komatsu S, Fukushima K, So S, Yoshida T, Tai K, Arai K, Fukumoto T

  ILLS2025, Jun. 2025, English, International conference

  Oral presentation


• Re-staining method with indocyanine green fluorescence imaging for laparoscopic liver resection

  Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  ILLS2025, Jun. 2025, English, International conference

  Oral presentation


• Nutritional Status Assessed by GLIM and PNI as Predictors of Textbook Outcome in Liver Resection for Hepatocellular Carcinoma

  Oji K, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2025, English, Domestic conference

  Poster presentation


• Outcomes of Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Major Hepatectomy or sectionectomy

  Tai K, Komatsu S, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2025, English, Domestic conference

  Poster presentation


• Re-staining method with indocyanine green fluorescence imaging for laparoscopic anatomical liver resection

  Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2025, English, Domestic conference

  Poster presentation


• Comparison of the utility of liver reserve and fibrosis indicators in predicting posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma

  Fukushima K, Komatsu S, Kido M, Gon H, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2025, English, Domestic conference

  Poster presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, May 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, May 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2025, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Mar. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Mar. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Mar. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Feb. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2025, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2025, Japanese, Domestic conference

  Oral presentation


• Comprehensive analysis of altered lipid and amino acid metabolism in patients undergoing pancreatoduodenectomy

  Nanno Y, Toyama H, Ishida J, Mizumoto T, Akita M, Arai K, Tai K, Yoshida T, So S, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Yanagimoto H, Kido M, Fukumoto T

  APA/JPS/CAP/IAP 2024, Dec. 2024, English, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Nov. 2024, Japanese, Domestic conference

  Public symposium


• Postoperative complications assessed by the comprehensive complication index (CCI) are associated with early recurrence after curative resection for biliary tract cancer

  Okazoe Y, Yanagimoto H, Akita M, Tsugawa D, Arai K, Yoshida T, So S, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Fukumoto T

  -, Oct. 2024, English, Domestic conference

  Poster presentation


• Clinical Significance of Laparoscopic 0-mm Margin Liver Resection for Vascular in Patients with Hepatocellular Carcinoma

  Shimura Y, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Arai K, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  -, Oct. 2024, English, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Oct. 2024, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Sep. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Sep. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Sep. 2024, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Public symposium


• Textbook outcomes in initial liver resection for hepatocellular carcinoma: a study with malnutrition grade by the GLIM criteria.

  Oji K, Urade T, Omiya S, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  -, Jul. 2024, English, International conference

  Poster presentation


• Clinical significance of hepatectomy for Hepatocellular Carcinoma Associated with Lymph Node and/or Distant Metastases

  Fukushima K, Komatsu S, Kido M, Gon H, Urade T, So S, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jul. 2024, English, International conference

  Poster presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2024, Japanese, Domestic conference

  Public symposium


• Comparison of laparoscopic partial liver resection for the superior and the inferior areas of segment 4

  Koizumi A, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2024, English, Domestic conference

  Oral presentation


• Clinical significance of hepatectomy for hepatocellular carcinoma associated with lymph node and/ or distant metastases

  Fukushima K, Komatsu S, Kido M, Gon H, Urade T, So S, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2024, English, Domestic conference

  Public symposium


• Treatment outcomes of hepatectomy and systemic chemotherapy based on the oncological criteria of resectability

  Komatsu S, Ishihara N, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2024, English, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• Laparoscopic SM0 liver resection for hepatocellular carcinoma adjacent to the hepatic hilum

  Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Ishida J, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  The 32nd international Congress of the European Association（EAES2024）, Jun. 2024, English, International conference

  Others


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, May 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2024, Japanese, Domestic conference

  Oral presentation


• Utility of ALBI grade for predicting prognoses in patients who underwent repeat hepatectomy

  Kusuhara T, Gon H, Kido M, Komatsu S, Fukushima K, Urade T, So S, Yoshida T, Arai K, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, International conference

  Poster presentation


• Multidisciplinary treatment strategy for macroscopic portal vein tumor thrombus

  Komatsu S, Yano Y, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Ishihara N, Yanagimoto H, Toyama H, Ueda Y, Fukumoto T

  The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, International conference

  Poster presentation


• A comparative study of laparoscopic liver resection for the segment 4 superior and inferior area

  Koizumi A, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, International conference

  Oral presentation


• The Efficacy of Total Tumor Volume in Patients with Colorectal Liver Metastases

  Shimura Y, Komatsu S, Fujisawa A, Kido M, Gon H, Fukushima K, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Fukumoto T

  The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, International conference

  Oral presentation


• -

  -

  -, Feb. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Feb. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jan. 2024, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Dec. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• The feasibility of laparoscopic liver resection with 0-mm surgical margin for hepatocellular carcinoma

  Shimura Y, Urade T, Kido M, Kuramitsu K, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  -, Nov. 2023, English, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Nov. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Sep. 2023, Japanese, Domestic conference

  Others


• -

  -

  -, Sep. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Sep. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Sep. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Sep. 2023, Japanese, Domestic conference

  Public symposium


• A comparative study of laparo-scopic liver resection for the segment 8 dorsal and ventral area

  Oji K, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  4th World Congress of International Laparoscopic liver Society（ILLS2023）, Sep. 2023, English, International conference

  Oral presentation


• Short-term impact of laparoscopic liver resection with 0-mm surgical margin for HCC

  Shimura Y, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Tsugawa D, Yanagimoto H, Toyama H, Fukumoto T

  4th World Congress of International Laparoscopic liver Society（ILLS2023）, Sep. 2023, English, International conference

  Oral presentation


• Laparoscopic segmentectomy2 versus left lateral sectionecto-my for liver tumors in segment2

  Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Omiya S, Shimura Y, Yanagimoto H, Toyama H, Fukumoto T

  4th World Congress of International Laparoscopic liver Society（ILLS2023）, Sep. 2023, English, International conference

  Oral presentation


• Impact of malnutrition diagnosed by the GLIM criteria on postoperative complications after pancreaticoduodenectomy for biliary tract cancer

  Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Okawa T, Omiya S, Arai K, Yoshida T, So S, Ishida J, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T

  45th ESPEN Congress, Sep. 2023, English, International conference

  Poster presentation


• Impact of malnutrition diagnosed by the GLIM criteria on outcome of elderly patients with hepatocellular carcinoma after liver resection

  Omiya S, Urade T, Komatsu S, Kido M, So S, Gon H, Fukushima K, Yoshida T, Arai K, Okazoe Y, Akita M, Ishida J, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  45th ESPEN Congress, Sep. 2023, English, International conference

  Poster presentation


• -

  -

  -, Jul. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jul. 2023, Japanese, Domestic conference

  Oral presentation


• A study for infectious complication of hepatectomies in patients with preexisting bilioenteric anastomosis

  Oji K, Urade T, Kido M, Kuramitsu K, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Poster presentation


• Successful biliary drainage using hybrid EUS-BD for stricture of choledochojejunostomy

  Tsugawa D, Yanagimoto H, Akita M, Arai K, Yoshida T, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Kuramitsu K, Goto T, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Poster presentation


• Intended destination for a board certified surgeon under 45

  Arai K, Komatsu S, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yoshida T, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Oral presentation


• Prognostic significance of malnutrition diagnosed by the GLIM criteria for resected extrahepatic cholangiocarcinoma: A single-center retrospective study

  Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Omiya S, Arai K, Yoshida T, So S, Ishida J, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Kuramitsu K, Goto T, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Oral presentation


• The optimal treatment strategy of therapeutic intervention using total tumor volume in patients with colorectal liver metastases

  Shimura Y, Komatsu S, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Goto T, Yanagimoto H, Toyama H, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Oral presentation


• Improvement in stapler pancreatic transection to reduce pancreatic fistula after laparoscopic distal pancreatectomy: twelve-year experience at a single high-volume center

  Ishida J, Toyama H, Asari S, Goto T, Nanno Y, Fukuoka H, Ami K, Akita M, Arai K, Yoshida T, So S, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Yanagimoto H, Kido M, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Oral presentation


• Anterior approach for open right hepatectomy for huge hepatocellular carcinoma

  Urade T, Kido M, Kuramitsu K, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Omiya S, Fujinaka R, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T

  -, Jun. 2023, English, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Jun. 2023, Japanese, Domestic conference

  Public symposium


• The factors of predicting over-time weight increase after liver transplantation

  Shimura Y, Kuramitsu K, Kido M, Komatsu S, Gon H, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Fukumoto T

  ILTS2023, May 2023, English, International conference

  Poster presentation


• Indication of liver transplantation in the treatment of newly categorized acute-on-chronic liver failure in Japan

  Kuramitsu K, Komatsu S, Kido M, Tsugawa D, Gon H, Fukushima K, Goto T, Yanagimoto H, So S, Arai K, Yoshida T, Ajiki T, Toyama H, Fukumoto T

  ILTS2023, May 2023, English, International conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Poster presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Apr. 2023, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Mar. 2023, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Dec. 2022, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Nov. 2022, Japanese, Domestic conference

  Oral presentation


• -

  -

  -, Oct. 2022, Japanese, Domestic conference

  Public symposium


• -

  -

  -, Oct. 2022, Japanese, Domestic conference

  Others

• 門脈・肝静脈同時結紮ラットモデルを用いた肝切除術前の予定残肝容量増大の最適化

  荒井 啓輔, 小松 昇平, 浦出 剛史, 福本 巧

  日本学術振興会, 科学研究費助成事業, 基盤研究(C), 神戸大学, 01 Apr. 2025 - 31 Mar. 2028


• Development of surgical stapler made by bio-absorbable Mg alloy

  Fukumoto Takumi

  Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Kobe University, 01 Apr. 2016 - 31 Mar. 2019

  Surgical stapler used to anastomose intestines or seal the vessels are usually made of titanium. They remain in the body permanently and may induce the complications like infection. In addition, they were usually restricted in the pediatric surgery due to the non-predictable influence of growth. We developed a biodegradable magnesium-zinc-calcium alloy stapler with good biological compatibility and enough sealing capability as a surgical stapler. We verified the safety and tolerability of this stapler for use in the canine gastric resection. Four dogs were used. We performed partial gastric resection by magnesium alloy stapler. The animals were euthanized at 2 and 4 weeks post-surgery. There were no postoperative complications and all dogs survived until the sacrifice. Laparotomy revealed that magnesium alloy stapler can successfully anastomose the stomach. Blood examinations detected no abnormalities.